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Foreword

Governance in Large Nonprofit Health Systems:
Current Profile and Emerging Patterns

Nonprofit healthcare organizations are not exempt from good governance. In fact, more today than ever, the
hospitals and health care systems of this country must have the discipline and commitment to organize their
governance structures and practices to provide forward-thinking leadership and stand up to scrutiny from any type of
evaluation and review. As we move from “sick care” organizations to “health care” organizations with accountability
for the health of the population of our communities from birth to end-of-life, the role of governance becomes even
more critical.
Fourteen of the largest and most notable health care systems in this country have been included in a research study to
examine their governance structures and practices in relation to nine benchmarks. The CEOs and board members
of these organizations were interviewed about their structures, processes and cultures, and then compared to national
best practices. The study also included close review of pertinent system documents.
This report is a must read for hospital and health care system CEOs and boards. It provides evidence-based
outcomes that will assist an organization in advancing its governance practices. This study outlines critical success
factors for governance structure and performance. It answers many questions that boards may be struggling with
today and provides advancing actions. The research methodology is thorough and reliable with specific outcomes
that provide high-performance opportunities.
Each CEO who participated in the research study has written about a best practice in his or her respective
organization that advances governance responsibility. These insights add a personal dimension to this report.
Sharing has always been a part of community-based, nonprofit healthcare. This report is a true example of that
commitment to learn from others. As one who has been blessed to be a part of this remarkable “space” known
as health care, I congratulate the research team who dedicated themselves to this important work. As clinical,
operational and financial performance continue to converge in health care organizations, quality and high-performing
governance practices, structures and culture must prevail.

Douglas D. Hawthorne, FACHE
Chief Executive Officer
Texas Health Resources
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I. Introduction1

In the United States, the healthcare field and societyat-large are in the midst of enormous turbulence. An
aging and increasingly diverse population, global and
nationwide economic problems of unprecedented
complexity, a federal government beset with political
conflicts that harm its ability to address important issues,
growing evidence of major disparities in healthcare
access, affordability, and quality,2 and the continuing
explosion in medical science and technology are
among the powerful forces that are affecting healthcare
providers, payors, and consumers.
These forces create daunting challenges for the clinical,
governance, and management leadership teams in
America’s hospitals, health systems, and other healthrelated organizations. The healthcare needs of the
communities they serve are growing while, at the same
time, available resources are increasingly constrained.
Meanwhile, the public’s satisfaction and trust in
healthcare organizations have declined.3
With respect to governance, the public’s unrest with the
cost and quality of services they receive from healthcare
organizations is accompanied by concerns about the
effectiveness of their governing boards. Public and
private organizations with oversight responsibilities for
nonprofit hospitals and systems including the Internal
Revenue Service (IRS), payors, rating agencies, and other
parties recognize that governance plays an important

role in shaping organizational performance, and they
are scrutinizing the practices of governing boards more
closely than in the past. As in other sectors, the boards
of healthcare organizations are being placed in the
“white-hot spotlight of public discourse.”4 Stakeholders
are calling for more accountability, greater transparency,
and better performance by the persons who manage and
govern these organizations.
In recent years, the governance of nonprofit hospitals
and health systems has received particular attention.
It is widely acknowledged that the governance of these
organizations has become more complex and that, on
the whole, the caliber of governance can and should be
improved.5 Except for basic requirements established
by the IRS, the Joint Commission, and state statutes,
universal standards for the governance of nonprofit
healthcare organizations have not been adopted.
However, over the past several years significant efforts
have been made by governmental agencies, voluntary
commissions and panels, and other parties to identify what
they believe to be the core features of effective governance
for boards and CEOs to use as benchmarks in efforts
to assess and improve governance performance.6 Some
of these benchmarks are well-established and widely
accepted; others are in formative stages. In Section III of
this report, a number of the benchmarks will be discussed,
and current board structures, processes, and cultures will
be compared to them.

According to the American Hospital Association, the total number of multi-unit health systems
(governmental and private) increased from 311 in 2000 to 427 in 2010, an increase of 37% in a decade.
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Concurrent with growing interest in improving
governance, America’s healthcare delivery system has
continued to evolve from mostly independent institutions
into larger groupings. According to the American
Hospital Association, the total number of multi-unit
health systems (governmental and private) increased
from 311 in 2000 to 427 in 2010, an increase of 37% in
a decade. Meanwhile, the proportion of the country’s
nongovernmental hospitals affiliated with nonprofit
systems increased from 53% in 2000 (1,602 of 3,003) to
65% in 2010 (1,876 of 2,904).7
It is clear that consolidation of America’s hospitals into
various forms of health systems is occurring and for many
reasons — including the hospitals’ needs for access to
capital and the support larger organizations can provide
— this trend is likely to continue.8 One of the striking
features of this transformation has been the development
of big, geographically-dispersed health systems. In 2010,
83 health systems (governmental and private) had annual
operating expenses of at least $1.5 billion and included a
total of 2,109 hospitals.9
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These large health systems include a large and growing
proportion of the USA’s healthcare facilities and provide
a substantial volume of inpatient and outpatient services.
However, while the body of knowledge regarding
governance in general has expanded in recent years, little
research has been focused specifically on governing boards
and governance practices in the nation’s largest health
systems.10 This is especially the case for nonprofit systems
as compared to investor-owned systems for which public
reporting requirements are somewhat more extensive.
The confluence of these developments — growing interest
in the responsibilities and performance of governing
boards in all sectors, advances in formulating benchmarks
of effective governance, and limited research-based
knowledge about governance in large nonprofit health
systems — provided the impetus for this study.

II. Purpose and Methodology

Purpose and Objectives of the Study
The overall purpose of this study is to examine board
structures, processes, and cultures in a set of the USA’s
largest private, nonprofit health systems and compare
them to several benchmarks of effective governance.
The study’s objectives are to:
• Increase knowledge and understanding of governance
in large health systems;
• Identify and describe some examples of “exceptional
governance features” that are in place in these systems;
• Identify areas where, on the whole, the governance of
health systems could be improved; and
• Produce information that can assist CEOs and board
leaders in assessing and enhancing board effectiveness.

Research Methodology
The methodology for this study includes four phases.
First, defining the study population and securing
agreements by systems to participate; second, based on
previous studies and expert panel reports, formulating a
composite listing of benchmarks of effective governance;
third, collecting comparable information regarding
board structures, processes, and cultures from interviews
with CEOs and board leaders using a structured
interview guide and from system documents; and fourth,
comparing this information to benchmarks of effective
governance and examining the findings using selected
variables and analytical tools.
These four phases can be described as follows:
Defining the study population and securing the systems’
participation. From its inception, the intent of this study
was to focus on a set of the country’s largest private,
nonprofit health systems. Working with the American
Hospital Association (AHA) in 2010, all of the country’s
private, nonprofit systems were ranked using a blend
of three measures of size: annual operating expenses
for the systems’ hospitals, the number of hospitals in
the system, and the number of counties in which these
facilities are located.

It was found that the 20 largest nonprofit health
systems collectively included 31% (573 of 1,876) of all
nongovernmental hospitals affiliated with systems and, in
addition, encompassed a broad array of other healthcare
programs such as medical groups, health plans, and
diverse health-related services. AHA staff and the
research team agreed these 20 organizations represent
the USA’s largest private, nonprofit health systems.
The next step was to extend invitations to participate in
this study. Starting with the largest system on the list
of 20, the team presented the research proposal to chief
executive officers and invited their systems’ involvement
in the study. In some instances, supplemental
information and/or conversations with other system
officials were required.
The research proposal that provided the basis for grant
support anticipated that at least 10 of the nation’s largest
private, nonprofit systems would participate in the
study. Ultimately, 14 of the 15 largest systems agreed to
participate and did so.11 Thus, these 14 systems comprise
the study population. They are:
• Adventist Health System Sunbelt Healthcare
Corporation, Altamonte Springs, Florida
• Ascension Health, St. Louis, Missouri
• Banner Health, Phoenix, Arizona
• Carolinas HealthCare System, Charlotte, North
Carolina
• Catholic Health East, Newtown Square, Pennsylvania
• Catholic Health Initiatives, Englewood, Colorado
• Catholic Health Partners, Cincinnati, Ohio
• Christus Health, Irving, Texas
• Kaiser Foundation Hospitals and Health Plan,
Oakland, California
• Mayo Clinic, Rochester, Minnesota
• Mercy Health, Chesterfield, Missouri
• Providence Health & Services, Renton, Washington
• Sutter Health, Sacramento, California
• Trinity Health, Novi, Michigan
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Of the 14 systems, eight are sponsored or controlled
by Roman Catholic entities. Three (Catholic Health
East, Catholic Health Partners, and Christus Health)
are sponsored by several religious communities and five
(Ascension Health, Catholic Health Initiatives, Mercy
Health, Providence Health and Services, and Trinity
Health) have adopted the public juridic person model.
This is an organizational arrangement that enables
religious communities to transfer control of health care
organizations to a new entity that, with substantial
laity involvement, operates in the name of the Catholic
Church and sustains the health ministry.12
One of the health systems in the study population is
affiliated with the Seventh-Day Adventist Church
(Adventist Health System), and one is operated by the
Charlotte-Mecklenburg Hospital Authority (Carolinas
Healthcare System). The other four systems (Banner
Health, Kaiser Foundation Hospitals and Health Plan,
Mayo Clinic, and Sutter Health) are independent,
nonprofit entities that do not have parent organizations.
Collectively these 14 systems include 460 of the 1,876
nongovernmental hospitals affiliated with private,
nonprofit systems (25%), an average of 33 hospitals per
system. In all instances, their organizational mission
and services include but extend beyond operating acutecare hospitals. For many, their hospital divisions are
only one important component of an increasingly broad
and diversified spectrum of health-related programs and
services: e.g., the Mayo Clinic, Mercy Health, and Kaiser
systems include four of the 11 largest medical group
practices in the United States.13 In various fashions,
all 14 systems are at present or are on the pathway
to becoming comprehensive, integrated healthcare
organizations.
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Formulating a composite listing of contemporary
benchmarks of effective governance. Based on review
of previous studies, current literature in the healthcare
field and other sectors, and consultation with several
experts in this realm, the research team formulated nine
contemporary benchmarks of effective governance, and
several basic indicators for each. In the selection process,
they were reviewed with current and former executives in
health systems that are not part of the study population
as an independent check on their appropriateness and
relevance. The benchmarks that were adopted are
pertinent to the governance of large health systems, and
the related indicators are considered to be reasonably
well-established and measurable. Certainly there are
other benchmarks and indicators of effective governance;
they are beyond the scope of this study.14
Site visits to systems in the study population. Studies
regarding governance in both investor-owned and
nonprofit organizations largely have been conducted
from afar. Several experts have advocated more field
work and closer engagement with executives and board
members.15 The intent of the site visits to the 14 systems
in the study population was to supplement information
obtained in advance and learn at first-hand the views
of senior trustees and CEOs regarding their respective
board’s structures, processes, and culture.
In preparation for the site visits, a standard set of
documents was requested and received from each system;
e.g., corporate articles of incorporation and bylaws;
organization charts; listings of system-level board
members and biographical information about them;
listings of board committees and their “charters”; selected
system-level policies pertinent to this study; position
descriptions for the board chair and CEO; information
about the system’s mission, vision, and goals; copies of a
system-wide “balanced scorecard” recently prepared for
the system board; and other documents.

Purpose and Methodology

Baseline information about each system obtained from its
documents and publicly-available sources was entered into
a Data Collection Guide prior to the site visits. This tool
was designed as a framework for recording comparable
information from official documents and from interviews
with the CEOs and board leaders regarding the benchmarks
of effective governance and related indicators. The team’s
experience in conducting previous studies of governance
in nonprofit hospitals and community health systems was
helpful in creating an efficient and workable tool.16
The team conducted site visits in the latter part of 2010
and 2011. The principal investigator participated in all 14
site visits and senior co-investigators participated in some
of them. Individual interviews were conducted with all
14 CEOs and a total of 57 board members. In all but one
instance, interviewees included the current board chair
and at least three other senior board members. Because of
scheduling factors, six interviews were conducted entirely
or in part via conference call. The interviews were 1.5
to 2.0 hours in length. Team members also met with
senior staff personnel to augment information obtained
from system documents and interviews. All interviewees
were assured of confidentiality, and consistently were
cooperative and cordial.

Comparing the data collected before, during, and after the
site visits to selected benchmarks of effective governance.
The data obtained from system documents, interviews
with the CEO and board members, and discussion
with system staff leaders were compiled by the research
team and tabulated. In doing so, the “data” about the
systems’ governance structures, practices, and culture
were transformed into “information.” In Section III, this
information is compared to the benchmarks of effective
governance and related indicators to determine where
they are being met and where gaps exist. In addition, this
information also is examined in relation to the system’s
operating performance using various analytical tools.
Information regarding limitations of the methodology
used in this study is provided in Appendix A.

In the process of reviewing the completed Data
Collection Guides after the site visits, follow-up
contacts were made with board members, CEOs, and/
or system staff when a response was missing or unclear.
Subsequently, the interview data were entered into a
Project Database and independently verified by another
member of the research team.
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III. Study Findings

An important responsibility in designing any study is
defining the variables that will be examined. Previous
work in the healthcare field and other sectors has
identified attributes that influence the performance of
governing boards. In recent years, considerable progress
has been made in translating them into benchmarks of
effective governance in healthcare organizations. Using
information provided by board members, CEOs, and
staff members and from system documents, this report
examines board structures, processes, and culture in
the health systems included in our study population
and compares them to nine benchmarks of effective
governance and related indicators.

BOARD STRUCTURE

With respect to board structures, this study focuses on
two key benchmarks of effective governance. They are:
1. Effective boards insist on governance policies and
structures that facilitate their efforts to perform the
board’s functions and fulfill its responsibilities.
2. Effective boards are comprised of highly dedicated
persons who collectively have the competencies,
diversity, and independence that produce
constructive, well-informed deliberations.
Indicators that relate to these two benchmarks include:

6

Formal Limits on the Number of Consecutive
Terms a Member Can Serve
Establishing limits on the number of terms a person
can serve has become widely-accepted as a sound
governance practice in all types of organizations.17
Some take the position that term limits may deprive the
board of valuable experience and institutional memory.
However, without clear limits and a formal requirement
to balance new appointments with retirements of
longtime directors, boards can become too large and/
or stale. It also becomes difficult to develop and
implement a meaningful board succession plan. As
stated in a recent Center for Healthcare Governance
report, term limits enable the introduction of “…fresh
thinking, expertise, and perspectives.”18 It is understood
that careful attention must be devoted to the timing
of term expirations to guard against losing an overly
large proportion of experienced board members in any
particular year. This typically is managed through the
use of staggered terms.
Eleven of the 14 large systems in this study population
(79%) have embraced the concept of term limits and
incorporated this provision into corporate bylaws
or policies. This compares to 64% for our country’s
hospitals and health systems as a whole, as determined by
a national survey conducted by the Governance Institute
in 2011.19
Among the 14 large systems that participated in this
study, the length of term appointments and the number
of consecutive terms a member can serve vary somewhat
from system to system. A common provision is threeyear terms with a limit of three consecutive terms for a
maximum of nine years on a board.

Study Findings

Formal Limits on the Number of Voting
Board Members
Traditionally, the boards of private, non-profit hospitals
and systems have been larger than the boards of public
companies. While the gap has narrowed over the years,
there continues to be a substantial difference. For public
companies, the average board size has remained in the
eight to nine range for several years.20 For hospitals and
health systems as a whole, the average size consistently
has been between 12 and 14 from 2005 to 2011.21
One mechanism for maintaining control of board size is to
establish formal limits on the number of voting members.
Establishing and honoring formal size limits is widely
accepted as a sound policy. The basic logic is to ensure
that the size is appropriate to meet the particular needs
of the organization. As expressed recently by the IRS:
“Very small or very large governing boards may not
adequately serve the needs of the organization. Small boards
run the risk of not representing a sufficiently broad public
interest and of lacking the required skills and other resources
required to effectively govern the organization. On the
other hand, very large boards may have a more difficult
time getting down to business and making decisions. If an
organization’s governing board is large, the organization
may want to establish an executive committee with delegated
responsibilities or advisory committees.”22
All 14 systems in this study population have adopted
limits on the number of voting members for their boards,
either in bylaws or corporate policies. Further, in all
cases the actual number of voting members is consistent
with their particular provisions.

Board Size
Neither in the healthcare field nor other sectors is there
an exact answer to the question of “how large a board of
directors should be.” The 2007 report of the HRETCenter for Healthcare Governance Blue Ribbon Panel
on Healthcare Governance advocated a range of nine
to 17 voting members for hospital and health system
boards.23 Several other authorities have offered similar
recommendations.24
As stated previously, the prevailing norm of America’s
public companies is considerably below this range —
averaging in the range of eight to nine voting members
— and some authorities advocate even smaller boards.
For example, Robert Pozen recently proposed that
public companies move to what he terms “professional
directorship.” Pozen argues for boards composed of
seven voting members including the CEO and six
independent directors, all with “…extensive experience
in the company’s lines of business” and with commitment
to devote “…at least two days a month on company
business beyond the regular board meetings.”25
Table 1 shows the distribution of the 14 system boards
by number of members. For 10 of the 14 systems, their
board size is consistent with the Blue Ribbon Panel’s
recommendation. Three boards have between 18 and
28 voting members; one board has 60 members. The
median size is 15 members, excluding the outlier with
60 voting members.
By any measure, the boards of these 14 health systems are
larger than the boards of America’s hospitals and health
systems as a whole and the boards of our country’s public
companies. In 2011, 83% of America’s Fortune 500 boards
had 12 or fewer voting board members.26 Only one of the
14 boards in this study population meets this criterion.
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TABLE 1

Size of System Boards
Number

Percent

0

0%

9 to 17 voting members

10

72%

18 to 28 voting members

3

21%

More than 28 voting members

1

7%

14

100%

Fewer than 9 voting members

Total

TABLE 2

Board Members’ and CEOs’ Views about the Size of Their Boards*
CEOs
(n = 14)

Board Members
(n = 57)

Total Responses
(n = 71)

It’s somewhat too large to be efficient.

15%

26%

24%

The present size is just about right.

71%

63%

65%

We should expand its size to provide broader input.

7%

4%

4%

Other

7%

7%

7%

Total

100%

100%

100%

*Throughout this report, test results are shown only when the observed differences were found to be statistically significant.

Table 2 shows the opinions of the systems’ board members
and CEOs about the current size of their boards. There
is virtually no interest in expanding the size of their
boards. In combination, 24% of the CEOs and board
members believe their board is somewhat too large, and
several boards are considering some degree of downsizing.
However, a majority are reasonably comfortable with the
current size of their boards.
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Senior board members who serve on the 60-person
board recognize clearly that it is exceptionally large and
somewhat unwieldy, but believe that — for their faithbased system with multiple sponsors — the benefits of
broad-based engagement in governance at the corporate
level outweighs the downside of having a very large
board. As would be expected, this board’s “executive
committee” (which includes 25 members) has substantial
responsibility.

Study Findings

Board Composition
Independence. The Sarbanes-Oxley Act of 2002
made the definition of “independence” more stringent
and increased the requirements for independent board
members on the boards of public companies. Other
regulatory and advisory bodies have adopted similar
positions; for example, the New York Stock Exchange
(NYSE) Listing Standards require a majority of a
company’s board members to be independent.
The overall impact on the composition of public
company boards has been striking. The proportion of
independent directors on the boards of Fortune 500
companies increased from 22% in 1987 to 84% in 2011.27
In fact, some authorities have cautioned that this shift
could have an adverse impact on board effectiveness by
reducing the number of non-independent directors with
great familiarity with the company and its sector.28

While the Sarbanes-Oxley Act currently applies only
to public companies, many of its key provisions have
been adopted voluntarily by nonprofit hospitals and
health systems. The Panel on the Nonprofit Sector
has taken the position that “… [a] substantial majority
of a public charity, usually meaning at least two-thirds
of the members, should be independent.”29 Several
authorities including the Coalition on Nonprofit Health
Care and the IRS (using somewhat different criteria)
have called for a majority of board members in nonprofit
organizations to be independent.30 In the contemporary
environment, this can be considered as a basic standard
for nonprofit healthcare boards.
For the purpose of this study, the term “independent
board member” was defined as persons who are “Not
a member of a sponsoring body such as a religious
congregation, not a full or part-time system employee,
and not directly affiliated with the system in any way
except serving as a voting board member.” Table 3 shows
that, in total, 60% of the members of the 14 system
boards in this study population meet these criteria.

TABLE 3

Independent vs. Non-Independent Board Members
Board Composition in
Faith-Based Systems
(n = 179)

Board Composition
in Secular Systems
(n = 95)

Board Composition
in all Systems
(n = 274)

Independent

49%

82%

60%

Non-Independent

51%

18%

40%

100%

100%

100%

P < .01*

*The chi-square test demonstrates significantly different proportions of independent board members in faith-based vs. secular systems.
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However, 82% of board members in the six secular health
systems meet the criteria for independence — virtually
identical to the current composition of America’s public
companies — while only 49% of faith-based system
board members meet those criteria. The difference
is statistically significant, and mainly reflects that the
composition of most faith-based system boards still
includes a substantial proportion of persons who are
affiliated with the previous or current religious sponsors.
The range of independent member composition varies
from 18% for one faith-based system to 100% for one
secular system, the single system in the study population
where the CEO is not a voting member of the board.
Diversity. In the healthcare field and other sectors, there
is general agreement that the membership of governing
boards must include persons with a strong blend of
pertinent experience and skills in order to perform their
fiduciary duties effectively. It is increasingly recognized
that the boards of nonprofit organizations also should
include members with diverse backgrounds including, but
not limited to, ethnic, racial, and gender perspectives.31

A coalition of major healthcare associations including the
American Association of Medical Colleges, the American
College of Healthcare Executives, the American Hospital
Association, and the Catholic Health Association are
collaborating in a new initiative — “A National Call
to Action” — to eliminate healthcare disparities in
the United States. One of this initiative’s three core
components is to increase diversity in governance and
management leadership.32
Table 4 shows the proportion of non-Caucasians serving
on the boards of the 14 large systems in this study
population. In total, 17% of the systems’ board members
are non-Caucasians; the proportion of those serving on
faith-based vs. secular boards is virtually identical. This
proportion is somewhat higher than the comparable
figure (10%) for hospitals that participated in a 2011
survey conducted by the AHA.33 The median proportion
of non-Caucasians on the boards of the 14 systems
was 17%; however, the proportion varied from no
non-Caucasians on one system’s board to 25% on another.

TABLE 4

Racial Composition of Large System Boards*
Board Composition in
Faith-Based Systems
(n = 179)

Board Composition
in Secular Systems
(n = 95)

Board Composition
in all Systems
(n = 274)

Non-Caucasian Members

17%

18%

17%

Caucasian Members

83%

82%

83%

100%

100%

100%

*Test results are shown only when the observed differences were found to be statistically significant.
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Table 5 shows the gender mix of the 14 systems’ boards.
While there is substantial variation from board to board,
the overall proportion of women serving on the boards of
the nine faith-based systems (40%) is significantly higher
than the corresponding figure for the secular systems (21%).
For the hospitals and health systems that participated in a
nationwide survey by the Governance Institute in 2011, 26%
of their board members were women.34
As compared to America’s Fortune 500 companies, the
boards of these 14 large, nonprofit health systems are
more diverse, both in racial and gender composition. In
2011, only 14% of Fortune 500 board members were
non-Caucasians and only 16% were women.35 It is
notable that 12% of Fortune 500 boards still included
no women.36 The boards of all 14 systems in this study
include several (two to 10) women.

Since eight of the 14 systems were established by one or
more congregations of religious women and all 14 are
considered to be progressive, it is not surprising that the
composition of their boards are more diverse than the boards
of both America’s hospitals and health systems as a whole
and public companies. It appears that our nation’s largest
nonprofit health systems are responding to what is, on
balance, a compelling case for diversity in board composition.
This includes a growing body of evidence that suggests
organizations and groups with more diversity in board
make-up and perspectives will out-perform others.37
With respect to executive leadership, during the period
of time this study was being conducted (2010-2012),
only one of the system’s CEOs was a woman (7%). This
is somewhat lower than the corresponding figure for
America’s hospitals and health systems as a whole (12%)
and somewhat higher than the figure for Fortune 500
companies (4%).38 It is clear that disparity still exists in
this segment of organizational leadership, both in the
healthcare field and in other sectors.

TABLE 5

Gender Composition of Large System Boards
Board Composition in
Faith-Based Systems
(n = 179)

Board Composition in
Secular Systems
(n = 95)

Board Composition
in all Systems
(n=274)

Women

40%

21%

33%

Men

60%

79%

67%

100%

100%

100%

P < .01*

*The chi-square test demonstrates significantly different proportions of women board members in faith-based vs. secular systems.
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Clinician Engagement. The National Quality Forum,
the Institute for Quality Improvement, and many other
prominent healthcare organizations have urged hospital
and health system boards to engage clinical leaders in
developing goals and strategies for improving patient care
quality and safety. For this and other reasons, involving
highly-qualified physicians who are committed to the
organization’s mission has become accepted as necessary
and effective governance practice.39 As stated by Barry
Bader et al:
“…a board’s membership should include independent,
creative, strategic thinkers who bring a broad range of
relevant skills to the table. It is difficult to imagine those
skills excluding medicine.”40
Recognition of the importance of physicians’ involvement
in healthcare governance is reflected in the results of several
national studies showing that they constitute approximately
20% of hospital and health system board membership.41 In
contrast, engaging leaders in the nursing profession in the
governance of healthcare organizations traditionally has not
been a common practice. Studies conducted in 2004-2005
and 2008-2009 found that nurses comprised only about
2% of nonprofit hospital and community health system
boards.42 Recognizing the vital role of nursing in providing
patient care and in determining the quality and cost of care,
a growing number of respected organizations including the
Robert Wood Johnson Foundation have urged hospital
and health system officials to consider the appointment of
highly-qualified nurse leaders to their boards. As Donald
Berwick has stated:
“It is key that nurses be as involved as physicians, and
I think boards should understand that the performance
of the organization depends as much on the well-being,
engagement, and capabilities of nursing and nursing leaders
as it does on physicians. I would encourage much closer
relationships between nursing and the board.”43
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Table 6 shows that, in combination, 14% of the study
populations’ board members are physicians and 6% are
nurses. Physicians are somewhat more prominent on the
boards of secular systems (18%) as compared to faithbased systems (11%); nurses comprise a larger proportion
of the faith-based system boards (9%) than the secular
system boards (2%). In both groups, clinicians collectively
constitute 20% of the systems’ voting board membership.
The finding that 6% of large system board members are
nurses is exactly consistent with the results of the AHA’s
2011 survey of American hospitals.44 These findings
appear to represent a shift in the direction that Dr. John
Combes, Dr. Susan Hassmiller, and others believe is “…
long overdue.”45 The finding that the overall proportion of
physician membership on these boards (14%) is somewhat
lower than the proportion on the boards of America’s
hospitals and community-based systems (approximately
20%) may be due, at least in part, to the more direct
responsibilities of local healthcare organization boards for
oversight of patient care quality and safety.
Board Member and CEO Views on the Current
Composition of Their System’s Board Composition. In
the one-on-one interviews with senior board members
and CEOs, all were asked to identify their principal
viewpoint regarding their board’s current composition
from among the four options shown in Table 7.
Thirteen percent of the CEOs and trustees felt the current
composition of their board was “just about right.” One in
five expressed the opinion that their board’s deliberations
would benefit from more racial and ethnic diversity around
the board table and at the committee level.
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TABLE 6

Clinician Composition of Large System Boards
Board Composition in
Faith-Based Systems
(n = 179)
Nurses

Board Composition
in Secular Systems
(n = 95)

Board Composition
in all Systems
(n = 274)

9%

2%

6%

Physicians

11%

18%

14%

Other

80%

80%

80%

100%

100%

100%

P < .05*

*The chi-square test demonstrates significantly different proportions of nurses in the board compositions of faith-based vs. secular systems.

TABLE 7

“What is your overall opinion about the current composition of your Board?”*
CEOs
(n = 14)

Board Members
(n = 57)

Total Responses
(n = 71)

The Board’s deliberations would benefit from
additional expertise.

50%

61%

59%

The Board’s deliberations would benefit from
greater diversity in perspectives.

29%

20%

21%

7%

7%

7%

14%

12%

13%

100%

100%

100%

The Board’s deliberations would benefit from having
more independent directors around the table.
The present composition is just about right.

*Test results are shown only when the observed differences were found to be statistically significant.

In combination, 59% of the CEOs and board members
expressed the view that their board composition and
dialog would benefit from additional expertise in one or
more areas. Two needs emerged as especially prominent:
20 of 71 CEOs and board members identified and
discussed the importance of adding more clinical
expertise. Eight spoke to the potential benefits of
adding one or more persons with extensive experience

in working with the executive and legislative branches
of the federal government; that is, as one senior trustee
expressed it, “persons who know how Washington DC
really works in today’s world.” Later sections of this
report will address, in more detail, the systems’ current
status and plans with respect to succession planning for
board members and senior management.
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Board Committee Oversight of Specific
Governance Functions

research team realized the specific names of committees
would vary from system to system. Therefore, in
reviewing system documents and interviewing board
members and CEOs, the team focused on identifying
and learning about the standing committees to whom
oversight responsibility was assigned.

The basic functions of the boards of nonprofit hospitals
and health systems are well-codified and widely
accepted.46,47 However, as stated in Section I, of
this report, there is considerable concern about the
effectiveness with which governing boards in nonprofit
(and investor-owned) organizations are performing those
functions. Numerous studies and expert panels suggest
boards that adopt a proactive role are more likely to
demonstrate effective performance than boards that are
less involved.48

Based on information obtained from system documents
and interviews with board members and CEOs, Table 8
shows the number and proportion of boards in this study
population that assigned oversight responsibility for seven
core governance functions to standing board committees.
The table also provides comparable information from the
AHA’s 2011 national survey of hospitals and systems.51

It is widely agreed that a well-organized committee
structure with knowledgeable, engaged members is one
of the keys to effective governance.49 As Barry Bader and
Elaine Zablocki have stated, “Working committees are
the engine that powers effective boards.”50
Based on their experience in serving on and studying
boards in a broad array of healthcare organizations, the

Given their complexity and importance, there is
general accord that — in the contemporary healthcare
environment — the audit and compliance,52 executive
compensation,53 and financial functions54 warrant close
oversight by standing board committees. This has
become a basic indicator of effective governance, and all
14 of the study population’s boards meet this standard.

TABLE 8

Boards that have Assigned Oversight Responsibility for Selected Governance Functions
to Standing Board Committees
Governance Function

Large Systems in this
Study Population
(n = 14)

All Hospitals Included
in AHA 2011 Survey
( n = 1,052)*

Audit and Compliance**

100%

51%

Executive Compensation**

100%

36%

Finance and Investments

100%

83%

Patient Care Quality and Safety

93%

75%

Board Education and Development

86%

60%

System Strategy and Planning**

79%

44%

Community Benefit**

43%

14%

*2011 AHA Health Care Governance Survey Report, op. cit., pp. 14-15.
**The P-value for the two-sample test of binomial proportions demonstrates significantly higher proportions of committees with oversight responsibility for these
governance functions in large systems vs. hospitals.
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Similarly, strong governance oversight of patient care
quality and safety programs,55 board education and
development,56 and system-wide strategy and planning
functions57 are widely recognized as fundamental duties
of healthcare organization boards in the contemporary
environment. Nearly all of the study population’s boards
have assigned clear oversight responsibilities for these key
functions to standing board committees; the other boards,
up to the present time, have chosen to perform these
governance functions as a “committee of the whole.” The
board of the sole system which, at the time of the research
team’s site visit, did not have a standing committee
with assigned responsibility for oversight of patient care
quality and safety was in the process of establishing a new
committee devoted to this governance function.
In contrast, only six of the 14 system boards (43%) have
standing committees with clear oversight responsibility for
system-wide community benefit policies, programs, and
services. Given growing concerns at national, state, and
local levels about the extent to which nonprofit healthcare
organizations provide community benefit, meet community
health needs, and deserve tax-exempt status, concerted
board-level attention to this area clearly is necessary and
important for governance and management leaders, both
at the local and system levels.58 The study population’s
governance policies and processes with respect to community
benefit programs are discussed in a later section of this report.

Written, Board-Approved Definitions of
Committee Responsibilities
Assigning oversight responsibility for specific governance
functions to standing committees in lieu of explicitly
deciding to perform those functions by the board as a
whole, is commonly accepted as a standard practice,
both in the healthcare field and other sectors. However,
when oversight responsibility is delegated to a board
committee, the committee’s role and duties should be
spelled out by the board in a written form that will be
clear to all parties. This is a fundamental indicator of
effective governance.59
Based on system documents and interviews with
CEOs and board members, Table 9 shows that the
standing board committees of all 14 systems in the
study population have clearly-defined responsibilities
that are spelled out in a written document (i.e., a bylaws
provision, a policy statement, or a formal committee
charter) that has been formally adopted by the system’s
board of directors. As shown in Table 9, a recent study
of governance in a group of 114 nonprofit community
health systems found that only 72% of their boards met
this standard.60

TABLE 9

Proportion of Health Systems Whose Standing Committees’ Responsibilities have been
Spelled Out in a Written Document and Formally Approved by the System Board
Large Systems in this
Study Population
(n = 14)

Nonprofit Community
Health Systems
(n = 114)*

100%

72%

Some, but not all, committees have such documents.

0%

21%

Other

0%

7%

100%

100%

Response
Yes, there are such documents for all standing Board committees.

P < .05**

*L. Prybil, et al, Governance in High-Performing Community Health Systems, pp. 12-13.
**The Fisher’s exact test demonstrates a significantly larger proportion of committees with responsibilities spelled out in a written document in
large vs. community-based systems.
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Board Executive Committees
In both nonprofit and investor-owned organizations, it
is quite common for governing boards to have “executive
committees” as part of their governance structure.
For example, a 2009 survey of nonprofit organizations
(health related and non-health related) conducted by
Grant Thornton LLP found that 88% of the boards
had executive committees.61 A 2011 study of public
companies by the National Association of Corporate
Directors found that, in these organizations, board
executive committees now are “nearly universal.”62
The specific role and responsibilities of board “executive
committees” vary widely. Some meet often and perform
substantial functions; others meet on rare occasions and
have very limited duties. If a board decides to establish
an executive committee, it is imperative to define clearly
the committee’s role and authority in board bylaws
and monitor the committee’s actions to ensure those
parameters are honored.63
The boards of 13 of the 14 large systems in this study
population have executive committees in place. As part
of the interview process during on-site visits, the CEOs
and board members of the 13 systems that have board
executive committees were asked “In your opinion, how
important is the Executive Committee to the overall
effectiveness of your Board?”

Table 10 shows the responses of CEOs and board members
in the 13 systems whose boards presently have executive
committees. Eighty-two percent of these CEOs and
board members think their board’s executive committee is
“Somewhat Important”; none believes it is “Unimportant.”
From the perspectives of these CEOs and board members,
their board executive committees have a limited and clearlydefined role which principally involves two basic functions:
first, to act on routine, non-strategic matters that require
formal board action between meetings of the full board,
and, second, to serve as a “sounding board” for the CEO
regarding topics on which he or she wishes to have informal
governance input and counsel, e.g., board meeting agenda
priorities. These CEOs and board members do not view
the executive committee as a decision-making body on
substantive issues.
Not surprisingly, two of the three CEOs and nearly all
of the board members who believe their board’s executive
committee plays a “Very Important” role are affiliated
with the two largest boards in the study population,
one with 60 members and one with 28 members.
Examination of the corporate bylaws and committee
“charters” for these two systems support these CEO and
board member assessments. In these two instances, the
boards’ executive committees operate with substantial
responsibility, and thus their performance clearly has
considerable impact on the overall effectiveness of the
systems’ boards.

TABLE 10

“In your opinion, how important is the Executive Committee to the overall effectiveness
of your Board?”*
CEOs
(n = 13)

Board Members
(n = 53)

Total Responses
(n = 66)

Very Important

23%

17%

18%

Somewhat Important

77%

83%

82%

0%

0%

0%

100%

100%

100%

Response

Not Important

*Test results are shown only when the observed differences were found to be statistically significant.
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Perceived Effectiveness of Board Committees
As part of the interview process, all CEOs and board
members were asked to share their personal assessment
of the overall effectiveness of their respective board’s
committees. As shown in Table 11, a majority of both the
CEOs and board members believe that, on the whole, their
board committees are well-organized and effective. As a
group, the CEOs’ views about the committees are more
sanguine than the trustees’ assessment.
In four of the 14 systems, 60% or more board members
believe the effectiveness of their committees’ performance
varies considerably, and that “…there is plenty of room
for improvement.” In two of these four systems, the
CEOs agree with this assessment. It is likely this will lead
to a serious review of those systems’ board committees’
roles, composition, and practices in the near future.

TABLE 11

“Based on your personal involvement and experience, how would you assess the overall
effectiveness of your Board’s committees?”*
CEOs
(n = 14)

Board Members
(n = 57)

Total Responses
(n = 71)

On the whole, our Board committees are highly organized and
perform their duties very effectively.

86%

58%

63%

For the most part, our Board committees do a good job, but this
varies from committee-to-committee, and there is plenty of room
for overall improvement.

14%

39%

34%

0%

3%

3%

100%

100%

100%

Response

I’m not sure.

*Test results are shown only when the observed differences were found to be statistically significant.
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BOARD PROCESSES
With respect to board processes, this study focuses on
five basic benchmarks of effective governance. They are:
3. Effective boards have clear definitions of their
authority and accountability and the decision-making
responsibility they have allocated to local operating
units in their system.
4. Effective boards require mutual understanding
regarding the respective roles of governance vs.
management, skillful board leadership, and excellent
board-management relationships.
5. Effective boards continuously improve board and CEO
performance by setting clear expectations, conducting
objective evaluation, and taking follow-up actions.
6. Effective boards are committed to establishing and
continually updating succession plans for the board,
board leadership positions, and, in concert with the
CEO, senior management positions.
7. Effective boards insist on meetings that are wellorganized, focus principally on system-wide strategy
and key priorities such as patient care quality and
community benefit, and employ board members’ time
and energy wisely.
Indicators that relate to these process-oriented
benchmarks include:

Board Accountability
In the USA, there is growing interest in the relationship
between large-scale organizations and their stakeholders.
Clarity in corporate responsibility and accountability is a
fundamental component in the foundation for effective
organizational governance.
“Corporate responsibility sets the terms of an implicit
contract between companies and society. This contract … is
enormously valuable to all parties. It establishes the shared
expectations on which people place their trust in companies,
and sets the ground rules within which companies compete
legitimately to provide the goods, services, jobs, and wealth on
which modern economies depend.”64
The state statutes under which both investor-owned
and nonprofit corporations are chartered call for their
governing boards to have overall responsibility for the
organization and the services or products it provides.
A large body of corporate law and several theories of
corporate governance have developed over the years, all
with the general intent of explaining how boards should
carry out their duties.65 In recent years, how effectively
governing boards perform those duties and fulfill their
accountability to shareholders, corporate sponsors, and
society at-large has become the subject of increasing
scrutiny.66 In the nonprofit sector, the tradition of
substantial autonomy is being reduced by increasing
demands for more information by governmental bodies
with oversight responsibility such as the IRS, public and
private payors, the media, and other stakeholders.67
In this context, it is imperative for the boards of all
nonprofit organizations to have a clear sense of the
parties to whom — as the stewards of the organization
— they are accountable and the ways in which their
accountability is fulfilled. As part of the interview
process, all board members and CEOs were asked “To
whom, in your opinion, is your Board accountable?”
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TABLE 12

“Is there a formal, written document that lists the specific powers that are reserved to
the party or parties to whom your Board is accountable?”*

Response

Faith-Based Systems
(n = 9)

Secular Systems
(n = 5)

All Systems
(n = 14)

Yes

100%

60%

86%

No

0%

40%

14%

100%

100%

100%

*Test results are shown only when the observed differences were found to be statistically significant.

For the board members and CEOs of faith-based
systems, the initial response to this question was prompt
and consistent. They believe their board’s principal
accountability is to the system’s religious sponsors or
the legal entity the sponsors have established to direct
and control the system and its local organizations; e.g.,
a “sponsors council“ of some type or, for the several
Catholic systems that have shifted to this organizational
arrangement, a public juridic person.68 For those
affiliated with secular systems, the most common view
is that their board’s principal accountability is to the
“patients and populations” their healthcare institutions,
health plans, and other programs serve. A substantial
portion of the trustees and CEOs of faith-based systems
also believe the organizations they govern are accountable
to the communities they serve.
In addition, many board members and CEOs express
the belief that — because a large and growing proportion
of their system’s revenues are provided by Medicare,
Medicaid, and other public programs — there is de facto
accountability to federal and state government. Nearly
all of these persons express the view that this is very likely
to become more pronounced in the coming years.

As a follow-up question, the board members and CEOs
were asked if there is a formal document that specifies
the powers that are reserved to the body or group to
whom their system’s board is principally accountable.
As would be expected, the board members and CEOs
in the nine faith-based systems, all of which have direct
accountability to a particular religious body or entity, are
well-aware of that relationship and the corporate bylaws
or other legal documents that codify it. In the secular
systems, four of which are independent entities that do
not have a parent organization or sponsor, the responses
were less uniform. However, these discussions and
subsequent review of corporate documents demonstrated
that all but two of the 14 systems in this study population
have formal statements of some nature that address their
board’s basic duties and accountability to another party or
parties (see Table 12).
In most instances, however, the boards’ accountability to
the “people, communities, and populations the systems
serve” — while easy to profess — is not spelled out in
a detailed fashion. The precise nature of the boards’
accountability in this realm and the specific mechanisms
by which their accountability is fulfilled generally are not
codified. Many board members and CEOs agree this is
a facet of their present governance model that requires
more attention and development.
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Allocation of Responsibility and Authority to
Local Organizations
In all complex, multi-level organizations, clarity in the
allocation of responsibility and decision-making authority
is imperative. A lack of clarity, misunderstanding, and/
or uncertainty will create operational problems and
adversely affect organizational performance. In the world
of health systems, especially those whose hospitals and
other delivery organizations are geographically dispersed,
a clear definition of the respective roles, responsibilities,
and authority between system-level and local leadership
is a fundamental indicator of effective governance.69
Twelve of the 14 health systems in this study population
presently have an organizational model that includes a
system-level board with overall governance authority and,
for their major community-based or regional organizations,
“local” boards that function with some degree of decisionmaking authority. In two instances, there are no local
boards, and the system-level boards directly exercise
governance authority over operating units. 70
In 13 of the 14 systems, there is a written, boardapproved document that specifies the allocation of
responsibility and decision-making authority between

system and local governance and/or management
leadership. The form of these documents varies; some
are incorporated in corporate bylaws, some are corporate
policies, and some take the form of an “authority matrix.”
Only one system, at this time, has not formulated its
practices into a formal board-approved document.
As part of the interview process, all board members
and CEOs were asked to characterize their views
on how their system’s current allocation of authority
between system and local leadership is viewed within the
organization. Table 13 shows their responses.
Their perceptions vary slightly, but most CEOs
and trustees felt their systems’ current policies and
practices on allocation of authority are reasonably
well (not perfectly) understood and accepted by board
and management leaders throughout the system; very
few believe there is substantive discord or problems
in this area. However, nearly all of these trustees and
CEOs are in accord that the allocation of responsibility
and authority within large, geographically-dispersed
organizations requires continuous efforts to build
understanding and on-going evaluation to identify
opportunities for improvement.

TABLE 13

“Which of the following, in your opinion, most accurately characterizes the present allocation
of authority between system-level and local leadership within your organization?”*
CEOs
(n = 14)

Board Members
(n = 57)

Total Responses
(n = 71)

The current allocation of authority is widely accepted by both
local and system level leadership.

57%

39%

42%

The level of acceptance is generally good, but it can and
should be improved.

43%

54%

52%

The level of acceptance is uneven and warrants system-wide
attention.

0%

5%

4%

Not sure.

0%

2%

2%

100%

100%

100%

Response

*Test results are shown only when the observed differences were found to be statistically significant.
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Board Chair - CEO Relationships
Creating and maintaining strong, trust-based
relationships among the CEO, the board chair, and the
board as a whole is universally recognized as a critical
factor in organizational performance and success. Clear,
distinct, and mutually-understood definitions of roles
and responsibilities are foundational to developing such
relationships.71
As a key ingredient in creating clear definitions and
mutual understanding, having formal descriptions of
the CEO’s and board chair’s duties has become a basic
hallmark of effective governance. Well-constructed
position statements that are approved by the board —
and reviewed and updated periodically — are a helpful
tool for all parties. Vague and/or out-dated position
descriptions are useless and potentially troublesome.

All of the 14 large systems in this study population have
formal, written descriptions of the CEO’s position that
have been adopted by the board. Twelve of the 14 boards
have adopted formal position descriptions for the board
chair; in one system (Kaiser Foundation Hospitals and
Health Plan), the CEO also chairs the board of directors.
This level of compliance compares very favorably with
the findings of other studies.72 Naturally the position
descriptions vary substantially, both in form and content.
Some are incorporated into corporate bylaws or policy
statements; others are free-standing documents. Some
are quite thorough and comprehensive; others are more
succinct with less detail. All, however, have been reviewed
and formally approved by the system’s board of directors.
As one way to gauge role clarity, all CEOs and board
members were asked to express their opinion on the
extent to which there is agreement among their board
colleagues on distinctions between the CEO’s and board
chair’s respective roles. As shown in Table 14, a large
majority of both CEOs and board members concur that
those distinctions are well-understood with their boards.

TABLE 14

“In your opinion, is there solid agreement among board members on the distinctions
between your CEO’s role and the Board Chair’s role?”*
CEOs
(n = 14)

Board Members
(n = 57)

Total Responses
(n = 71)

Yes

86%

91%

90%

No

7%

2%

3%

Not Applicable**

7%

7%

7%

100%

100%

100%

Response

*Test results are shown only when the observed differences were found to be statistically significant.
**In one system, the CEO also chairs the board of directors.
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TABLE 15

“How would you describe the working relationship between your CEO and Board Chair?
That is, how does it work?”*
CEOs
(n = 14)

Board Members
(n = 57)

Total Responses
(n = 71)

Our CEO-Board Chair relationship is consistently excellent.

86%

91%

90%

Our CEO and Board Chair generally work together, but the
relationship could be better.

7%

4%

4%

Our CEO and Board Chair relationship can and should be improved.

0%

0%

0%

Not Applicable**

7%

5%

6%

100%

100%

100%

Response

*Test results are shown only when the observed differences were found to be statistically significant.
**In one system, the CEO also chairs the board of directors.

As a way to get a sense of how systems’ CEOs and
board chairs work together, interviewees were asked to
express their views on their CEO-board relationship. As
shown in Table 15, the predominant view among both
board members and CEOs is that these relationships are
“consistently excellent.”
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Board Evaluation Process
On-going assessment of its structure, processes, and
culture is a fundamental duty of every board of directors.
Numerous bodies with regulatory or quasi-regulatory
responsibilities in the healthcare field and other sectors
(e.g., the Joint Commission and the New York Stock
Exchange) have called for boards to conduct selfassessments on a regular basis. Accordingly, engaging in
some type of formal board evaluation — with or without
assistance by an external, independent party — has
become the norm. A 2011 study of public companies
by the National Association of Corporate Directors
found that nearly all companies (91%) regularly conduct
full board evaluations and a very large proportion
perform committee evaluations (83%).73 A 2011 survey
conducted by the Governance Institute found that 92%
of health system boards “…engage in a formal process to
evaluate its own performance at least every two years.”74
However, board evaluation processes vary greatly in rigor
and value. As stated by Beverly Behan:
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“Rather than a robust and rigorous process that helps boards
figure out whether they’re doing the right work in the right
way, we too often see a mechanical exercise in ticking off the
boxes on a formulaic checklist often borrowed from another
company. A board can get away with that and confidently
report one more area where it complies with New York Stock
Exchange rules. However, it will waste an opportunity if
it does nothing to increase the effectiveness or value to the
company and its stakeholders … almost every board could
find ways to do its job better.” 75
In short, there are two basic indicators of effective
board evaluation in all organizations: serious, on-going
examination of the board and its performance and
demonstrated commitment to make actual changes as
a result of the evaluation process.76 Studies have found
that objective evaluation together with follow-up board
development steps can improve board performance.77
The 14 systems’ board members and CEOs were asked
if, in their opinion, their boards engage in formal board
evaluation activities. Table 16 presents their responses
compared to findings from a 2009 study of governance
in 114 nonprofit community health systems. Consistent
with other recent studies, these data affirm that around
90% of the boards in both groups conduct some type of
formal board evaluation on an annual or biennial basis.

Two of the 14 large systems in this study population do
not, at this time, perform formal, overall board evaluation
on a regular basis. However, these two systems — and
most of the other 12 — do employ other, less formal
types of “board evaluation” activities such as post-board
meeting reviews in executive sessions. One of these two
boards presently is considering the establishment of a
more formal board evaluation protocol.
The second part of the benchmark — actually making
changes based on findings from the board evaluation
process — is a more stringent test. The information
displayed in Table 17 represents one probe into the
willingness of boards in large, geographically-dispersed
health systems and the boards of smaller, community
health systems to take such actions.
In both groups, slightly over half of the board members
and CEOs believe their board evaluation processes have
resulted in substantive changes in board composition,
practices, and/or dynamics. Most of these leaders
were able to give specific examples of actions taken by
their boards as a direct or indirect outcome of board
assessment efforts during the past two years; e.g., reallocating some board meeting time from routine reports
to long-range strategic issues; upgrading board education
programs; and modifying board committee structures
through adding, deleting, or consolidating committees.

TABLE 16

“Does your system Board regularly engage in formal evaluation of how well it carries out
its duties?”*

Response

Directors and CEOs of
14 Large Systems
(n = 71)

CEOs of 114 Community
Health Systems
(n = 114)**

Yes, either annually or biennially

86%

90%

No

14%

10%

100%

100%

*Test results are shown only when the observed differences were found to be statistically significant.
**L. Prybil, et al, Governance in High-Performing Community Health Systems, op. cit., pp. 17-18.
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TABLE 17

“Over the past two years, has the Board evaluation process resulted in actions that have
substantially changed the Board’s size, composition, or practices.”*

Response

Directors and CEOs of 14
Large Systems (n = 71)

CEOs of 114 Community
Health Systems
(n = 114)**

Yes

52%

56%

No

32%

42%

Not Sure or Did Not Answer

16%

2%

100%

100%

*Test results are shown only when the observed differences were found to be statistically significant.
**L. Prybil, et al, Governance in High Performing Community Health Systems, op. cit., pp. 18-19.

However, about a third of these board members and
CEOs clearly believe their investment of time and other
resources in board evaluation exercises during the past
two years did not result in substantial changes; several
others “were not sure.” It is possible that, in some
instances, the evaluation processes simply concluded
there was no need for changes in the board’s structure,
processes, or practices; that is, everything was fine as is.
However, these data do raise serious questions about the
extent to which the current board evaluation practices
actually are improving governance, at least in a large
segment of these health systems.
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Each of the board members and CEOs in the 14 large
systems also were asked to share their personal viewpoint
on the effectiveness of their board’s formal board
evaluation process. Their responses, shown in Table 18,
suggest that a large proportion of both board members
and CEOs have reservations about their current board
evaluation processes. In combination, only 30% of these
system leaders believe their current board evaluation
processes are “thorough” and have produced “substantial
improvements in board performance.” Their responses to
this question reinforce concerns about the present state of
board evaluation in these systems surfaced by the findings
presented in Table 17. (As previously stated, at the time
the site visits were conducted, two of the 14 systems did
not have a formal, overall board evaluation program in
place; one of the boards is engaged in considering the
possibility of establishing one.)

Study Findings

TABLE 18

“Which of the following statements most accurately represents your view regarding the
overall effectiveness of your Board’s current evaluation process?”*
CEOs
(n = 14)

Board Members
(n = 57)

Total Responses
(n = 71)

Our Board evaluation process is excellent and has resulted in
substantial improvements in Board performance.

36%

28%

30%

A process is in place and has been somewhat beneficial.

50%

54%

54%

0%

2%

1%

14%

16%

15%

100%

100%

100%

Response

The process is not well-organized and not very productive.
We do not have a formal board evaluation process in place at this time.

*Test results are shown only when the observed differences were found to be statistically significant.

CEO Evaluation Process
For all corporate organizations, appointing the CEO,
establishing performance expectations and evaluating his
or her success in meeting those expectations are among
a governing board’s most essential duties. Numerous
studies have shown that — for organizations, teams,
and individuals — having clearly-defined goals tends
to enhance performance.78 For the CEOs of any
organization, large or small, evaluating their performance
against pre-established expectations in a fair, objective
fashion is beneficial for the CEO, the board, and the
organization as a whole. Doing this well is widely
accepted as a basic hallmark of effective governance.

National studies in the healthcare field and other
sectors indicate that a large majority of boards formally
evaluate their CEOs’ performance in some fashion.
For example, a 2011 survey of public companies by the
National Association of Corporate Directors found
that approximately 70% of boards collaborate with their
CEOs in setting financial and non-financial goals.79
A 2011 Governance Institute study showed that 91% of
the participating hospital and health system boards have
adopted and utilize “…a formal process for evaluating
their CEOs’ performance.”80
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On-site interviews with the CEOs and board members
in the 14 large systems found that all of the boards
regularly evaluate their CEOs’ performance in relation
to pre-established expectations or criteria on a regular
basis. As shown in Table 19, in seven of the 14 systems,
the boards’ compensation committees are charged with
leading the evaluation process; in all seven instances, the
board chair either serves on the compensation committee
or works closely with it in the evaluation process. In four
systems, the current CEO evaluation protocol calls for
the board chair personally to lead the CEO evaluation
process; in all four of these systems, the board chair
engages other board members in the process.

All of the board members and CEOs also were asked to
express their opinion on the overall effectiveness of their
system’s current CEO performance evaluation process.
As shown in Table 20, a strong majority of both the
CEOs and board members believe the current process
“…produces clear performance expectations and assesses
actual performance fairly.”
Unfortunately, this is not the case in many organizations
in the healthcare field and other sectors. A recent study
by the American College of Healthcare Executives
found that 82% of CEOs were not given performance
expectations when they initially were employed, and 66%
reported that no formal evaluation process was conducted
at the end of their first year in the position.81 Numerous
experts have expressed serious questions and concerns
about the rigor and efficacy of CEO evaluation in both
nonprofit and investor-owned organizations.82

TABLE 19

“Who has lead responsibility for leading the CEO evaluation process?”*

Response

Faith-Based Systems
(n = 9)

All Systems
(n = 14)

Board Chair

3

1

4

Board Executive Committee

0

1

1

Board Compensation Committee

5

2

7

Ad hoc group appointed by the Board Chair

1

1

2

Total

9

5

14

*Test results are shown only when the observed differences were found to be statistically significant.
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Secular Systems
(n = 5)
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TABLE 20

“Which of the following statements most accurately describe your overall view of the
effectiveness of your Board’s current CEO evaluation process?”*
CEOs
(n = 14)

Board Members
(n = 57)

Total Responses
(n = 71)

The process produces clear performance expectations for the CEO
and assesses actual performance fairly.

79%

74%

75%

A process is in place and has been somewhat beneficial for the
CEO and our organization.

21%

24%

24%

The process is not well-organized and not very productive.

0%

0%

0%

Has not yet participated in our CEO evaluation process

0%

2%

1%

100%

100%

100%

Response

Total

*Test results are shown only when the observed differences were found to be statistically significant.

Succession Planning Processes
In the organizational context, “leadership succession
planning” should address the needs for clinical,
governance, and management leadership talent. Having
highly-dedicated and skillful leaders in key roles in all
three realms with capable persons in line to succeed them
when needed is essential to sustain organizational success
in our rapidly changing and increasingly challenging
societal environment.
The concept of “leadership succession planning” includes
several basic components: on-going efforts to define
leadership needs and how those needs are evolving as the
organization’s internal and external environment changes;
assessing existing talent in relation to the organization’s
current and projected needs; building a strong leadership
development program to enhance the existing talent base
and recruit additional talent where required; and systematic
planning to identify well-prepared individuals who have the
competencies and motivation to step into key positions and
perform effectively when they are called upon.

The concept is straight-forward, and the potential
benefits for the organizations which embrace and execute
it effectively are clear. This is why organizations such as
the Securities Exchange Commission, rating agencies,
and other bodies with oversight responsibilities in
many sectors are devoting more scrutiny to leadership
succession planning.83 Ensuring that well-designed
leadership succession programs are in place and
functioning well has become a fundamental indicator of
effective governance.
Unfortunately, the evidence suggests that many boards,
both in the healthcare field and other sectors, fall
short. To illustrate, a 2011 survey by the National
Association of Corporate Directors found that only one
third of America’s public companies had a formal CEO
succession plan in place.84 A 2010 study by the American
College of Healthcare Executives found that only 44%
of hospitals had succession plans for their CEO, 39% for
their chief nursing officer, and 36% for the chief financial
officer.85 A 2011 Governance Institute study showed
that only 41% of the participating hospitals and health
systems employ “…an explicit process of board leadership
succession planning to recruit, develop, and choose future
board officers and committee chairs.”86
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In the on-site interviews, all board members and CEOs
were asked about the current status of succession planning
for board and senior management positions within their
systems. As shown in Table 21, these interviews and
subsequent conversations with system staff indicate that
six of the 14 systems (43%) have some form of succession
plans in place, both for board leadership and senior
management positions, including the system CEO.
Another four systems (29%) have succession plans in place
for the CEO and other senior management positions, but
not for board leadership. In general, the development of
succession planning is somewhat more advanced in the
secular systems than in faith-based systems. However,
virtually all of the board members and CEOs in systems
that have initiated board and/or management succession
planning programs express the view that their current
programs are in “early stages of development” and will
require much more work during the coming months and
years. They also are in accord that leadership succession
planning is critically important to the long-term success of
their systems.

Board Oversight of Patient Care Quality
and Safety
Extensive efforts to improve patient care quality and safety
are being made by national organizations such as the
Institute for Healthcare Improvement, the Hospital Quality
Alliance, and the National Quality Forum as well as by
health system leaders at the local level. There is evidence
that improvements in some areas are being made.87
However, a series of studies by the Institute of Medicine,
the Commonwealth Fund, and other authorities show
that the overall quality of clinical services provided by
healthcare institutions continues to be uneven and needs
to be improved.88 In March 2011, the U.S. Department
of Health and Human Services promulgated a National
Quality Strategy intended to “… promote quality
health care in which the needs of patients, families, and
communities guide the actions of all those who deliver
and pay for care.”

TABLE 21

“Has your board adopted formal succession plans for Board and senior management positions?”*

Faith-Based Systems
(n = 9)

Secular Systems
(n = 5)

All Systems
(n = 14)

Yes, for Board chair, for Board committee chairs, for the CEO,
and for other senior management positions.

33%

60%

43%

For Board leadership positions but not for senior
management positions.

11%

0%

7%

For the CEO and other senior management positions but not for
Board positions.

23%

40%

29%

We have not yet adopted any formal succession plans.

33%

0%

21%

100%

100%

100%

Response

*Test results are shown only when the observed differences were found to be statistically significant.
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The governing boards of America’s hospitals and health
systems have a special role in meeting these challenges.
Ensuring that organizational standards for patient care
quality and safety are adopted and that processes for
monitoring and improving clinical services are in place
clearly are among the boards’ most fundamental duties.89
It is imperative for boards to understand their legal and
moral responsibility in this realm; engage with clinical
and management leadership in establishing policies,
standards, and metrics for patient care quality and safety;
and monitor the organization’s performance in relation to
them. Boards also must ensure that appropriate actions
are taken by clinical and management leadership when
performance does not meet the established standards.
In the contemporary healthcare environment, meeting
these obligations has become a basic expectation for
hospital and health system boards. This has been
reinforced by new leadership standards set forth by the
Joint Commission in January, 2009, and by provisions of
the Affordable Care Act of 2010.
“The [Affordable Care Act’s] aim is to achieve optimal results
in terms of the overall quality of care as well as its efficiency,
cost, safety, and timeliness … boards, which are legally
accountable for the quality of care their institutions provide,
need to develop and implement effective quality oversight
processes to achieve these objectives …90
It seems likely that the Centers for Medicare and
Medicaid Services (CMS), the Department of Justice, and
other regulatory bodies will hold the board of directors
accountable if a healthcare institution is not providing
patient care services that meet established quality standards

and the board “…knew or should have known about it,
yet did nothing while the institution continued to submit
claims to Medicare and other payers …”91 However, some
studies have raised concerns about the extent to which
hospital and health system boards are focused on patient
care quality and safety. For example, a study conducted by
Ashish Jha and Arnold Epstein in 2007-2008 found that
only half of the board chairs in a nationally representative
sample of nonprofit hospitals identified clinical quality
as one of their board’s two top priorities for governance
oversight.92 A 2011 Governance Institute survey found
that only 74% of health system boards have standing
committees on quality and/or safety.93
This study of governance in 14 large systems examined
several aspects of the board’s oversight of patient care
quality and safety and found evidence of substantive
engagement. As shown in Table 8 and discussed
earlier in this report, nearly all of the boards (93%)
have established a standing committee with oversight
responsibility for patient care quality and safety. Through
interviews with senior board members and CEOs and
review of system documents, this study examined the
boards’ current role with respect to setting the system core
measures and standards for patient care quality. Table 22
shows the findings. In 11 of the 14 systems, the board
of directors formally adopts system-wide measures and
standards. In two cases, the board’s standing committee
on quality has been delegated responsibility to adopt
the measures and standards and present them to the full
board. During the period of time when this study was
being conducted, the remaining board was engaged in
re-examining its role and practices with respect to
oversight of patient care quality and safety.
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TABLE 22

The System Board’s Role with Respect to System-Wide Measures and Standards for
Patient Care Quality*

Faith-Based Systems
(n = 9)

Secular Systems
(n = 5)

All Systems
(n = 14)

The Board formally adopts core measures and standards for quality
of patient care.

78%

80%

79%

A Board committee adopts the core measures and standards and shares
them with the Board, but the Board does not formally adopt them.

11%

20%

14%

Measures and Standards for quality of patient care are not
established at the system level; this function is handled by local
organizations in our system.

11%

0%

7%

100%

100%

100%

Response

*Test results are shown only when the observed differences were found to be statistically significant.

TABLE 23

“Has your system’s Board adopted specific action plans in the past 12 months directed at
improving system performance with respect to patient care quality and safety?”*

CEOs
(n = 14)

Board Members
(n = 57)

Total
(n = 71)

Yes

79%

80%

80%

No

14%

18%

17%

7%

2%

3%

100%

100%

100%

Response

I’m not sure

*Test results are shown only when the observed differences were found to be statistically significant.
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In the one-on-one interview process, all board members
and CEOs were asked if their system board “…regularly
receives written reports on system-wide and hospitalspecific performance in relation to established measures
and standards for the quality of care.” All 14 CEOs
and all 57 board members independently responded
affirmatively. Their opinions were verified by examining
“scorecard” reports and other system documents that are
prepared for and presented to these boards.
Finally, as a test of the boards’ willingness to address issues
or problems that are surfaced by reports they receive, the
board members were asked if, in the past 12 months, their
system’s board had “…adopted specific action plans directed
at improving system performance in patient care quality and
safety.” Table 23 presents their responses to this question.
The congruence between the views of board members and
CEOs on this important issue is striking: among both
groups, four out of five respondents stated that their boards
had adopted one or more “action plans” within the past
year. Many were willing and able to give concrete examples.
Predictably, these “action plans” varied widely. They ranged
from asking the CEO and system staff to address a specific
quality of care issue at an institution in their system and
prepare a special report for consideration at an upcoming
board meeting to directing the board’s quality committee
and staff to “take a fresh look” at certain quality measures
and targets adopted in the past.
Contrary to some other studies, the input provided directly
by these board members and CEOs — in combination with
system documents such as quality committee charters and
board scorecard reports — suggest high levels of interest and
engagement in addressing their responsibilities for oversight
of patient care quality and safety. Nearly all of the board
members and CEOs readily acknowledge the complexity
of these responsibilities and the shortfalls they perceive
in their current policies and practices. They view these
policies and practices as “work-in-process” and recognize
the need for continuous assessment and improvement in
them. However, based on these findings, it certainly appears
that the boards of these large nonprofit systems are heeding
Donald Berwick’s call to embrace “stewardship of quality” as
a fundamental board duty.94

Board Oversight of Community Benefit
Policies and Programs95
The landmark work of the Commission on Hospital Care
during and after World War II led to enactment of the
Hospital Survey and Construction Act of 1946 (Public Law
79-725). This legislation, commonly termed the “HillBurton Act,” became Title VI of the Public Health Service
Act. It represented the first major policy instrument for
shaping hospital and health services planning in the United
States. To become eligible for federal grants for hospital
construction projects, states were required to establish
hospital planning agencies, assess existing facilities in relation
to current and projected community needs, and set priorities
on a statewide basis. In the decades that followed, the HillBurton Act enabled thousands of hospital construction
and renovation projects, reshaped America’s health services
delivery system, and introduced the concept that nonprofit,
tax-exempt healthcare facilities should serve defined
community needs.96
Historically, nonprofit hospitals and health systems were
accorded tax-exempt status on the premise that a fundamental
reason for their existence was providing charity care to persons
who required healthcare services but were unable to pay for
them. The original (1946) Hill-Burton legislation required
facilities receiving grants to provide charity care for 20 years
to eligible individuals unable to pay for their services; facilities
funded with grants under Title XVI in later years were
required to provide uncompensated care in perpetuity.97
In 1965, Congress enacted Public Law 89-97 which
established the Medicare and Medicaid programs and
significantly expanded health insurance coverage for
elderly and poor Americans. In 1969, the IRS issued
Revenue Ruling 69-545 which shifted the rationale
for granting tax-exempt status to nonprofit healthcare
institutions from providing charity care to providing
“community benefits.” In Revenue Ruling 69-545, the
IRS reasoned that providing healthcare services for the
general benefit of the community inherently is a charitable
purpose, outlined the factors that would be considered in
granting tax-exempt status, and, in doing so, created the
so-called “Community Benefit Standard.”98
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As time passed and the healthcare field and society as
a whole experienced major economic, demographic,
and political changes, many parties in both the public
and private sectors began to raise questions about the
adequacy and appropriateness of the Community Benefit
Standard as the basis for providing tax-exempt status for
nonprofit healthcare institutions.99 A number of voluntary
healthcare organizations including the American Hospital
Association, the Catholic Health Association, the
Health Research and Education Trust, the Public Health
Institute, and the VHA have encouraged hospitals and
health systems to document the services they provide
and how those services benefit the communities they
serve.100 However, several studies by the IRS, the
General Accounting Office, and other organizations
documented wide variability in definitions and amounts
of “uncompensated care” and other forms of community
benefit provided by nonprofit healthcare institutions.101,102
These studies — in combination with a series of hearings
by legislative bodies including the House Ways and
Means Committee and the Senate Finance Committee
at the federal level and growing need for revenues at the
state and local levels — generated serious questions about
nonprofit hospitals’ exemptions from income, property,
and other taxes.
These issues have contributed to the adoption of various
forms of community benefit requirements (such as a specific
level of charity care and/or standard reporting rules) for
nonprofit healthcare institutions in about half of the states.103
In some locales, hospitals’ traditional exemptions from
property taxes are being challenged on the basis of their levels
of charity care.104
At the federal level, continuing concerns about the utility
of the IRS Community Benefit Standard, the absence
of agreed-upon “community benefit” definitions, and
wide variation in the amounts of uncompensated care
and other community benefits provided by nonprofit
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hospitals and systems led, in 2007, to substantial
revisions to the IRS Form 990, “Return of Organization
Exempt from Income Tax,” and corresponding
instructions. The redesigned form consists of a common
document that must be completed by all applicable
tax-exempt organizations and a series of schedules that
organizations may need to complete depending upon
their particular roles and activities. Phased in beginning
with the 2008 tax year, this was the first major revision to
Form 990 since 1979.
For healthcare institutions, the revised Form 990 and the
new Schedule H require significantly more details about
charity care, other types of community benefits provided
by the organization, the expenses related to these services,
and other information than in the past. According to the
IRS, Schedule H was intended to “ … combat the lack
of transparency surrounding the activities of tax-exempt
organizations that provide hospital or medical care.”105
Since its adoption in 2007, the Form 990 and related
schedules have been refined somewhat but basically
remained intact since then. However, the Patient
Protection and Accountable Care Act (the “Act”)
adopted by Congress in 2010 amended the IRS code
by adding Section 501(r)(3). It requires every hospital
facility operated by a 501(c)(3) organization to conduct
a “community health needs assessment” with input from
interested parties in the community at least once every
three years, develop an implementation strategy to address
community needs identified through that process, and
make the results widely available to the public. Hospitals
with a July 1- June 30 fiscal year are required to complete
a community health needs assessment, set priorities, and
adopt implementation plans by June 30, 2013.106 Details
remain to be worked out, but if the Patient Protection
and Affordable Care Act and IRS Code Section 501(r)(3)
remain in place, they will have substantial impact on the
nation’s nonprofit hospitals and systems.
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TABLE 24

“Has the Board adopted a formal, written statement that defines overall goals and guidelines
for the system’s community benefit program?”*

Faith-Based System
(n = 9)

Secular Systems
(n = 5)

All Systems
(n = 14)

Yes

78%

40%

64%

No

11%

60%

29%

Not Clear

11%

0%

7%

100%

100%

100%

Response

*Test results are shown only when the observed differences were found to be statistically significant.

While recognizing the Act was new and federal guidance
regarding Code Section 501(r)(3) would not be available
for some time, the interviews with system board members
and CEOs did include several questions regarding their
particular system’s community benefit programs as they
exist at this time. The first was “Has your board adopted
a formal, written statement that defines overall goals
and guidelines for your system’s community benefit
program?” In combination, 61% of the trustees and CEOs
answered affirmatively; many were able to discuss the
genesis and content of their system’s policy and position
in some detail. A review of system documents support
these finding and indicate that, at this time, nine of the
14 systems (64%) have board-approved policy statements
regarding their community benefit programs in place.
CEOs and board leaders in several of the remaining
systems are giving consideration to developing and
adopting policy statements of this type.

Among the basic aims of the Act are improving patient
care quality and safety, reducing the growth in healthcare
costs, and improving coordination among providers of
healthcare services. As one strategy for achieving these
aims, the Act promotes the development of “accountable
care organizations” (“ACOs”) which, as a general construct,
can be defined as “ … groups of providers who are willing
and able to take responsibility for improving the overall
health status, care efficiency, and health care experience
for a defined population.”107 Implicit in the ACO and
other provisions of the Act is encouragement to improve
communication and coordination between healthcare
providers in the private sector and public health agencies.
This theme also has been affirmed by the Institute of
Medicine’s 2012 report, “Primary Care and Public Health:
Exploring Integration to Improve Population Health” and
a recent report by the Urban Institute.108
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As one way to gauge the participating systems’ current
policy positions on coordination between their local delivery
organizations and public health agencies, the board members
and CEOs were asked if their system’s board requires (not
just “encourages”) their local organization to collaborate with
local public health agencies in their vicinities. The information
presented in Table 25 shows that, at this time, such
requirements are not common. Only four board members
and one CEO, all affiliated with a single secular system,
indicated that collaboration with local public health agencies
in assessing community health needs and setting community
benefit priorities is a system-wide requirement for their local
organizations. However, in recognition of the nationwide
need for greater focus on prevention and population health,
many board members and CEOs expressed support for the
idea of promoting stronger communication and coordination
between their local institutions’ leadership teams and local
public health agencies.

In the contemporary environment, organizations in virtually
all sectors of society face resource constraints and must
set resource allocation priorities carefully. As stated by
Michael Porter and Mark Kramer, “No business can solve
all of society’s problems or bear the cost of doing so.”109 For
America’s hospitals as a whole, uncompensated care (charity
care and bad debt) increased from $21.6 billion in 2000 to
$39.3 billion in 2010, an increase of 82% in that decade.
This trend clearly has affected the availability of resources
for other categories of community benefit activities.110 For
this and other reasons, developing and adopting formal plans
and setting clear priorities for community benefit programs
has emerged as a basic indicator of effective governance in
healthcare organizations.111

TABLE 25

“Does your Board require your local organizations to collaborate with local public health
agencies in assessing community needs and setting community benefit program priorities?”*

Response

CEOs
(n = 14)

Total
(n = 71)

Yes

7%

5%

6%

No

93%

93%

93%

0%

2%

1%

100%

100%

100%

Not Sure

*Test results are shown only when the observed differences were found to be statistically significant.
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(n = 57)
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In this study of governance in large nonprofit systems, all
board members and CEOs were asked if, in their opinion,
their system’s board has required their local organizations
to develop and adopt a formal community benefit plan
that identifies specific priorities for its community benefit
program. Nearly half of the board members and CEOs
responded affirmatively. A review of system documents
supports their opinions and, as shown in Table 26, seven of
the 14 systems (50%) in this study population — principally
but not exclusively faith-based systems — have directed
their local leadership teams to develop formal plans with
priorities, strategies, and metrics for their community
benefit programs. In several instances, these expectations
specify that the process of developing local plans must
consider and address certain system-wide priorities. If the
provisions of IRS Code Section 501(r)(3) go into effect
and resources become further constrained, the development
and adoption of formal community benefit plans at both
the system and local levels of nonprofit health systems will
become increasingly prevalent.

Allocation of Board Time and Effort
The time its board members are able and willing to devote
to governance functions is one of an organization’s most
important assets. The manner in which board meetings are
organized and how time is allocated is a key determinant of
board effectiveness in all types of organizations.112
The board members and CEOs who were interviewed as
part of this study were asked to estimate the proportion of
board (not board committee) time allocated to two critical
topics in meetings of their system board during the past
twelve months. Those topics were, first, patient care quality
and safety and, second, strategic thinking and planning.

TABLE 26

“Does your Board require your local organizations to adopt a formal community benefit plan
that identifies specific priorities and strategies for its community benefit program?”*

Faith-Based System
(n = 9)

Secular Systems
(n = 5)

All Systems
(n = 14)

Yes

67%

20%

50%

No

33%

60%

43%

0%

20%

7%

100%

100%

100%

Response

Not Clear

*Test results are shown only when the observed differences were found to be statistically significant.
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As reported earlier in this report, 13 of the 14 boards in
this study population have established standing committees
on patient care quality and safety; virtually all of the
board members and CEOs interviewed in this study view
setting direction and providing oversight of their systems’
performance in this area as one of their most important
duties. With respect to allocation of board meeting time to
reports and deliberations regarding patient care quality and
safety during the past year, the combined estimates by board
members and CEOs of the 14 boards ranged from a low
of 10% to a high of 35%. The median estimate for the 14
boards was 23%; the mean estimate was 22%.
Governing boards in all types of organizations frequently
are criticized for focusing on current operating performance
and short-term issues as compared to the major strategic
problems and opportunities that confront the organization.113
In surveys of boards in both public companies and nonprofit
organizations, directors often rank “strategic planning
and oversight” as one of their boards’ top priorities.114
Many authorities have urged boards to devote more time
and attention to strategic or “generative” thinking and
deliberations; however, recent studies do not demonstrate
that this shift is occurring.115
In this study, board members and CEOs were asked to
give their best estimates of board meeting time devoted
to strategic thinking and planning during the past year.
The combined estimates by board members and CEOs of
the 14 boards ranged from a low of 15% to a high of 53%.
The median estimate for the 14 boards was 32%; the mean
estimate was 30%.
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Perhaps the most striking insight from these discussions with
board members and CEOs was the consistent expressions
of interest and commitment by both board members and
CEOs to increase their boards’ focus on strategic thinking
and deliberations. Virtually all recognize the importance
of this governance responsibility in our increasingly volatile
healthcare environment; many discussed steps their boards
already have taken and/or are planning to take to re-align
their traditional board meeting agendas and practices to
create more time for various forms of strategic assessment
and deliberations. These include, for example, adopting a
formal board policy to commit at least half of every board
meeting to long-term strategic thinking and planning.
Another board now blocks at least two hours of every board
meeting to focus on a particular strategic issue or opportunity
their system needs to address.
It must be recognized that the data regarding allocation of
board meeting time simply represent the “best estimates” of
board members and CEOs, not actual measurements, and
longitudinal data are not available for comparison. However,
these estimates in combination with narrative comments
provided by the board members, CEOs, and system staff
members are congruent and clearly suggest two conclusions:
first, on the overall basis, these 14 system boards over the
past year have devoted approximately half of their board (not
committee) meeting time to deliberations regarding quality
and safety and to strategic thinking and planning. Second,
virtually all of these boards and their CEOs are making
intentional efforts to re-balance their board meetings to
provide more time for engagement in active deliberations
with less time devoted to routine reports and presentations.
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BOARD CULTURE
With respect to board culture, this study focuses on two basic
benchmarks of effective governance. They are:
8. Effective boards intentionally create a culture that
nurtures enlivened engagement, mutual trust,
willingness to act, and high standards of performance.
9. Effective boards expect their CEOs to demonstrate
exceptional leadership and management skills, high
personal and professional standards, and strong
support for the role of governance.

Over time, either deliberately or not, every board of
directors creates a governance culture — a pattern of
beliefs, traditions, and practices that come to prevail
when the board meets to perform its duties. As stated
by Barry Bader:
“Like their organizations, governing boards have a culture too.
The pivotal importance of culture in distinguishing the effective
from the ineffectual board has been apparent at least since the
downfall of the Enron Corporation. Observers attributed Enron’s
collapse in part to a passive, management-driven board of
directors. Despite talented members and a well-defined structure,
directors failed to ask hard questions or display the independence
needed to detect egregious accounting irregularities and unethical
conduct by senior executives.”116
Some boards, like Enron’s and many others, are
insufficiently dedicated with a passive culture and low
performance standards. This combination generally
results in ineffective governance.117 In both the healthcare
field and other sectors, there is growing conviction that
effective governance requires a healthy board culture with
commitment to proactive engagement, high performance
standards, and rapt attention to making and executing
decisions.118

Healthy Board Culture
Examining and trying to understand the culture of any
organization or group is quite challenging. Based on the
work of a panel including senior board leaders, CEOs,
governance consultants, and university faculty members with
experience in board service and research convened by HRET
in 2007 and other studies, the research team selected seven
features that, if present, indicate the existence of a healthy,
effective board culture.119 Board members and CEOs of the
14 large systems who participated in this study were asked
to express their views on the extent to which their system’s
board demonstrates these seven characteristics.120 Table 27
displays their responses in comparison to the views of CEOs
who participated in a recent study of governance in 114
nonprofit community health systems.
These data suggest that nearly all trustees and CEOs in
these 14 large systems believe their boards consistently
demonstrate commitment to their system’s mission and
honor their conflict of interest and confidentiality policies.
However, less than 60% of them feel their board leaders
“hold board members to high standards of performance”
or that “robust engagement and respectful disagreement
consistently are encouraged.” In combination, only onethird of the trustees and CEOs feel their systems’ board
meetings consistently are “well-organized and focus
principally on strategic deliberations rather than receiving
information.” This finding is consistent with Section III (B)
of this report which documents the commitment by many
board members and CEOs to shift a larger proportion of
board time and effort from reports on routine operations to
strategic thinking and deliberations. In general, the views of
the CEOs of these 14 large systems on these indicators of
effective board culture are similar to the view of community
health system CEOs. None of the observed differences are
statistically significant.
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TABLE 27

Board Member and CEO Opinions on Whether or Not their Boards Demonstrate Selected
Indicators of Effective Board Culture*
Board Members of
14 Large Systems
(n = 57)

CEOs of 14 Large
Health Systems
(n = 14)

The Board’s actions always demonstrate deep commitment to
our organization’s mission.

93%

93%

89%

There always is a strong focus on honoring Conflict of Interest
and Confidentiality policies.

93%

86%

n/a

There always is an atmosphere of mutual trust among the
Board members.

75%

71%

70%

Our system’s performance (financial and clinical) always is
tracked closely by the Board and actions are taken when
performance does not meet our targets.

74%

93%

72%

Board leadership always holds Board members to high
standards of performance.

58%

57%

42%

Robust engagement and respectful disagreement always
is encouraged.

51%

50%

54%

Board meetings are well-organized and focus principally on
strategic deliberations, rather than receiving information.

32%

43%

n/a

Indicators of Healthy, Effective Board Culture

CEOs of 114 Community
Health Systems
(n = 114)**

*Test results are shown only when the observed differences were found to be statistically significant.
**Prybil, et al, Governance in High-Performing Community Health Systems, pp. 28-29.

Approach to Decision-Making
The role and responsibilities of a governing board requires it
to make decisions that shape the organization and its future
direction. The manner in which a board approaches and
conducts its decision-making processes is a fundamental
indicator of its culture and has major impact on the
organization’s performance.121
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As one way to probe this dimension of the boards’ cultures,
board members and CEOs were asked to characterize
their board’s overall approach to “… making decisions on
important issues over the past 12 months.” Table 28 displays
their opinions, again in comparison with the views of 114
community health system CEOs who responded to the same
question as part of a previous study.
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TABLE 28

“Over the past 12 months, how would you characterize your system Board’s approach to
making decisions on important issues?”*
Board Members of
14 Large Systems
(n = 57)

CEOs of 14 Large
Health Systems
(n = 14)

The Board tends to be actively engaged in discourse and
decision-making processes. Most Board members are willing to
express their views and constructively challenge each other and
the management team.

63%

57%

70%

The Board is involved in some issues, but its level of
engagement is inconsistent. The Board’s decision-making
process would benefit from more dialog and debate.

35%

43%

29%

The Board tends to be passive and reactive in its approach to
decision-making. We need to find ways to get the Board much
more engaged.

0%

0%

1%

Other

2%

0%

0%

100%

100%

100%

Overall Approaches to Decision-Making on Major Issues

CEOs of 114 Community
Health Systems
(n = 114)**

*Test results are shown only when the observed differences were found to be statistically significant.
**L. Prybil, et al, Governance in High-Performing Community Health Systems, op. cit., p. 30.

These data show that a substantial majority of board
members (63%) and CEOs (57%) view their respective
board’s current approach to decision-making positively.
On the whole, board members are slightly more sanguine
about their approach than CEOs, but the difference is
modest and not statistically significant. The CEOs of 114
community health systems studied in 2008-2009 view their
boards’ approach to making major decisions somewhat more
positively than the CEOs of the 14 large systems in this
study population, but, again, the observed difference is not
statistically significant.
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CEO Commitment to Board Development

Senior Staff Support for the Board

As part of the interview process, all board members were
asked to describe their CEO’s level of commitment to
developing a governing board whose culture has the
characteristics shown in Table 27. Virtually without
exception, the board members’ responses to this question
were positive and highly complimentary. It is clear that
this group of CEOs — and their commitment to assist in
building a strong, healthy board culture — is recognized
and greatly appreciated by their board members.

Table 29 provides another indicator of CEO commitment to
strong governance. Because solid staff support for boards is
a critical determinant of their effectiveness, board members
were asked if all standing board committees are staffed by
senior members of their system’s leadership team. Ninetyone percent of the board members replied affirmatively to
this question. Their opinions were verified by reviewing
system documents and through discussions with the system
CEOs and staff members. In only one system did board
members express the view that the overall caliber of staff
support for board committees — and for the board as a
whole — was somewhat less than satisfactory.
In combination, these findings indicate that the CEOs
of these 14 systems are strongly committed to effective
governance and, on the whole, provide excellent support
for their board and board committees.

TABLE 29

“Are the standing committees staffed by senior members of your system’s leadership team?”*

CEOs
(n = 14)

Board Members
(n = 57)

100%

91%

Some, but not all, do.

0%

9%

No, they do not.

0%

0%

100%

100%

Response
Yes, all standing committees have senior staff support.

*Test results are shown only when the observed differences were found to be statistically significant.
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Executive Sessions of the Board
Over the past twenty years, the practice of having
“executive sessions” of the board has evolved from being
rare to becoming commonplace, both in the healthcare
field and other sectors. Among public companies, this
practice now is virtually universal.122 A 2011 survey
conducted by the Governance Institute found 73% of the
health systems that responded now schedule executive
sessions before or after every board meeting.123

Executive sessions of this nature provide an opportunity for
board members to candidly exchange views on governance
issues such as board succession planning while still ensuring
solid communications and coordination between the board
and the CEO. Establishing the tradition of executive
sessions of this nature as part of every board meeting with
the understanding and support of the CEO is an effective
governance practice. It also becomes an important feature
of the board culture and reflects mutual trust and respect
between the board and the CEO.

Executive sessions organized into two segments, one part
without the CEO or other management team members
present and one part with the CEO present, have become
widely accepted as a standard practice of effective boards.124

Table 30 shows that nine of the 14 system boards in this
study population (64%) hold executive sessions as part
of every board meeting; the balance (36%) have such
sessions sometimes, but not always.

TABLE 30

Does the Board Hold an Executive Session at the End of Board Meetings Without the CEO or
Other Management Staff Present?*

Faith-Based System
(n = 9)

Secular Systems
(n = 5)

All Systems
(n = 14)

Yes

67%

60%

64%

Sometimes, but not always

33%

40%

36%

0%

0%

0%

100%

100%

100%

Response

No

*Test results are shown only when the observed differences were found to be statistically significant.
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“The healthcare environment is changing dramatically and

EMERGING GOVERNANCE PATTERNS AND will continue to do so, but our system has been successful
SELECTED FEATURES125
and comfortable with the status quo. The question is, can
This section of the report has two parts: first, an overview
of several overall patterns or “themes” that emerged from
this study of governance in 14 large, nonprofit health
systems and, second, a synopsis of one particular feature
of the governance model currently in place in each of
these systems.

Emerging Governance Patterns
Each of the 14 health systems that participated in
this study is unique in certain respects. Their genesis,
their evolution over the years, the particular set of
communities and populations they presently serve, their
current mission, and their vision and goals for their future
all differ in various respects. However, from this study
of their governance structures, processes, and cultures
including interviews with their senior board leaders and
CEOs, several common patterns of governance emerge.
These overall patterns appear consistently in all or most
of the systems and in all parts of the country. These
emerging patterns include the following:
1. Our nation’s economic, political, and social
environment is demanding major changes in all
of these systems.
Virtually all of the systems’ board leaders and CEOs
recognize that the rapidly changing environment
will require fundamental changes in their system’s
organizational structure, policies, programs, and, in
many cases, their traditional mission and current vision.
As one CEO stated during the interview process:
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our system change — really change — to better address the
changing needs of an aging population and a much greater
emphasis on prevention and health promotion? Can we reinvent ourselves as a system to focus on improving community
health status as well as providing acute care services much
more efficiently?”
Healthcare in the USA is in the midst of turbulent
change, and healthcare providers are facing difficult
issues and great uncertainty. All of these large systems
are engaged in various forms of transformational
change; e.g.: re-designing their corporate structures
to facilitate large-scale diversification; aligning closely
with physicians and other providers to create a more
integrated continuum of care; investing in for-profit
ventures; and partnering with insurers to form new
“accountable care organizations.” The boards and CEOs
realize that making major changes is imperative; making
those changes while preserving their system’s core values
clearly is one of their fundamental challenges.
2. Increasing focus by boards on system-wide strategy
and strategic issues
In all of the systems that participated in this study,
the boards and CEOs are engaged in a distinct shift in
governance focus and allocation of time. The pattern
that clearly is emerging involves a growing emphasis
on strategic issues, deliberations, and decision-making.
All of the systems are in the midst of reforming their
board structures, processes, and practices to accelerate
that shift. In addition to now-standard practices such as
board retreats and the use of a “consent agenda” format
for board meetings, some examples of steps being taken
by the systems’ boards to enable greater attention to
system-wide strategy and strategic issues include:
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• A policy decision by one board to devote 50% of every
board meeting to strategic issues and deliberations.
• Blocking at least two hours of every board meeting to
a specific challenge or opportunity felt to have major
implications for the organization’s future direction.
• Re-structuring the board agenda to place items
requiring board decisions and strategic issues that
call for board deliberations as the first segment
of every board meeting. Routine committee and
management reports are distributed in advance of
the board meetings, with the understanding that the
information therein will not be replicated in verbal
presentations.
• Requesting every board committee, as a standing
agenda item at every committee meeting, to devote
concerted time to identifying issues in their realm of
responsibility (e.g., quality and safety) that could have
major, long-term strategic impact on the system; then
— with appropriate explanation and information —
proposing such items for strategic deliberations at a
future board meeting.
Proper board oversight of their system’s operations in
relation to established goals and targets is obviously
essential. However, it is clear that — in the contemporary
environment — it is increasingly important for boards to
devote attention to strategic thinking and deliberations.
In various ways and at differing speeds, the boards of all
14 systems are in the process of making this shift. As
a board chair of one faith-based system stated in the
interview process:
“As a system, what can and should we become in the future?
What is the best direction for our health ministry? What
should be our vision for the future and what strategies should
we adopt for getting there? These are the issues our board and
management colleagues must focus on.”

3. Patient care quality and safety has risen to become a
principal board priority.
The board leaders in these 14 health systems clearly
recognize their board’s fiduciary and moral responsibility
for quality and safety. Thirteen of the 14 boards now
have standing committees to provide direction and
oversight and all of the boards now routinely receive
written reports on system-wide and hospital-specific
performance in relation to quality measures. The
interviews with senior board members and CEOs as well
as conversations with system staff associates consistently
reflect that patient care quality and safety has become a
high governance priority. As stated by the CEO of one
of these systems:
“Getting ready for ‘value-based purchasing’ which is emerging
in many forms across the country is one of our system’s greatest
challenges. To be successful in the future, all providers of
healthcare services must make dramatic advancements in
improving quality and reducing costs. Multi-state providers
such as we are will have special challenges because private and
governmental payors in different states will adopt a variety of
approaches and requirements.”
The findings of this study suggest their oversight
responsibility for patient care quality and safety has
the boards’ attention. However, many of the boards
and CEOs are wrestling with the best approaches and
methods for fulfilling this responsibility. What are the
proper quality and safety measures against which boards
should set targets and monitor performance? What is
the most appropriate approach to articulate the respective
roles of the board as a whole, the board committee
on quality and safety, the system CEO and his or her
management team, and local leadership? These are
among the questions that the boards of health systems
and other providers of healthcare services throughout
the country are addressing.
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The array of quality and safety measures being
disseminated by CMS, the National Quality Forum,
and other parties is large and growing constantly. As
stated recently by Michael Wagner:

It seems apparent that the leadership of many health
systems, large and small, would benefit from clear,
pragmatic guidance in this complex realm.

For many faith-based and secular health systems,
a fundamental question that emerges is this: In an
increasingly complex healthcare environment where
public and private payors and the public at-large are
demanding healthcare providers to enhance access to
services, improve quality, and reduce costs, to whom are
nonprofit health systems and their boards accountable for
their performance, and what are the best mechanisms for
fulfilling that accountability? What are the best methods
for ensuring proper accountability to the communities and
populations these systems exist to serve? These are among
the questions that are emerging and which a growing
number of boards and CEOs are now addressing.

4. Defining or re-defining the systems’ key stakeholders
and accountability protocols

5. Increasing board focus on system-wide community
benefit programs and community health needs

As these systems become larger and more complex, many
board leaders have identified the need to revise their
organizational models and re-think their definitions
of key “stakeholders” and traditional mechanisms for
accountability. For example, as discussed earlier in this
report, several Roman Catholic systems have adopted
the Public Juridic Person model which enables religious
congregations to transfer control to a new Catholic entity
with substantial laity leadership. This has involved major
changes in their traditional accountability to former
religious sponsors and new forms of accountability
to the Vatican. Other systems, both faith-based and
secular, have made or are contemplating organizational
changes that alter their traditional forms and practices
with respect to accountability. For example, one
large secular system recently eliminated hospital-level
boards and replaced them with “regional” boards that
now have defined levels of responsibility and decisionmaking authority for the system’s hospitals and other
healthcare programs in their geographic area. Among
the implications of this organizational change is that the
system no longer can expect its hospital boards to be a
primary link for communications with and accountability
to the particular communities and populations those
hospitals serve.

The boards of nine of the 14 large systems in this study
population have adopted policies or some other formal
statement that define overall goals and guidelines for
their systems’ community benefit programs; others are
considering such action. About half of the systems now
require their local organizations to develop and adopt
formal plans that identify specific priorities and strategies
for their community benefit programs. Moreover,
discussions with the systems’ board members and CEOs
reflect board awareness of the national spotlight on
what nonprofit organizations are doing in this area.
It is apparent their awareness has been heightened by
passage of the Patient Protection and Affordable Care
Act which, among its many provisions, places several
new requirements on tax-exempt hospitals related to
their community benefit plans and programs. As stated
in Section III (B) of this report, these new requirements
include conducting community health needs assessments
in concert with public health and other interested parties
in the community, prioritizing these needs, developing
implementation strategies, and making these strategies
and results available to the public.

“Current health care leaders are finding it increasingly
difficult to make progress in the quality terrain as the answer
to the question, ‘What is quality?’ is an expanding and
moving target.”126
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While the regulatory details remain to be developed, it
seems clear these new requirements will have considerable
effects on tax-exempt hospitals and their parent systems. As
Richard Umbdenstock, President and CEO of the American
Hospital Association, stated recently “… it’s important to
identify critical interfaces between public health and acute
care and open a new, mutually-beneficial chapter in dialog
and collaboration between the hospital and public health
communities.”127 The boards and CEOs of America’s
health systems will serve a key role building these linkages.
6. Succession planning for board and senior management
is becoming a governance priority
Identifying and developing future leaders for the board of
directors and the management team in a systematic fashion is
critically important in all organizations. Unfortunately, there
is abundant evidence that leadership succession planning in
the healthcare field as well as other sectors traditionally has
been — and continues to be — spotty at best.
This study provides evidence that leaders of many health
systems in this study population have recognized the
importance of succession planning and now are devoting
attention and resources to it. Six of the 14 systems now have
some form of succession plans in place, both for board and
senior management positions; five others have instituted
succession planning processes for either management or
board leadership positions but not both. Most of the CEOs
and board leaders who were interviewed acknowledge that
developing and sustaining solid succession plans is essential,
that the programs they presently have in place need a lot
of improvement, and express commitment to ensuring this
happens in the near future.
7. Boards and CEOs in most of these large systems
are giving priority attention to board development
and culture
Every board of directors, over time, develops a
governance culture — a pattern of beliefs, traditions,
and practices that prevail when the board convenes

to carry-out its duties. Each board is responsible for
shaping its own culture, and the culture that exists will
have a major impact on the board’s performance.
Among the large health systems included in this study,
the board cultures are varied and, in all cases, there
are some gaps between the cultures that presently
prevail and key indicators of effective board culture.
However, among the board leaders and CEOs of all
14 systems, there is substantial agreement that healthy,
high-performing boards are characterized by clear
understanding of their role and responsibilities, active
engagement in their governance duties, mutual trust,
and willingness to take decisive actions. Further, as a
whole, these board leaders and CEOs express strong
commitment to board evaluation and development,
including on-going attention to cultural characteristics.
8. High level of CEO support for the role of governance
and solid, trust-based board-CEO relationships
When asked to describe their respective CEO’s
commitment to developing strong system-level
governing boards with a healthy culture, nearly all
board members expressed the view that their CEO’s
support is consistently high and greatly appreciated
by them and their board colleagues. All of the boards
have adopted a formal description of their CEO’s and
board chair’s duties and believe that, at this time, their
respective roles are well-understood, both by the board
and the management team. With very few exceptions,
the members believe their board of directors and board
committees receive solid staff support from senior
members of the management team. Ninety percent of
the board members characterize the working relationship
between their board and CEO as “consistently excellent.”
In brief, the prevailing pattern is clear: the CEOs of these
14 large health systems understand and respect the role of
governance, provide strong support for their board and board
committees, and enjoy excellent, trust-based respect in their
board-CEO relationships. These ingredients are vitally
important in building and maintaining effective governance.
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Selected Governance Features
Early in the process of conducting site visits to the
corporate offices of systems in this study population
and visiting with senior board leaders, CEOs and staff
associates, it became clear to the research team that all of
their governance models were distinctive in various ways.
In addition, the systems’ board and management leaders
demonstrated clear understanding of particular strengths
of their current governance model, as well as areas where
they believe improvements are needed.
These conversations prompted the following question
to each system’s leadership team: “Would you please
identify and describe one feature of your system’s current
governance model — its structure, policies, practices,
or culture — that you believe has proven, over time,
to be particularly beneficial?” All agreed to do so.
Subsequently, guidelines with respect to length and
format were provided to the systems and, during the fall
of 2011, all of the systems prepared concise descriptions
of the governance features they selected to showcase.
The research team greatly appreciates the support of the
systems’ CEOs and leadership teams in selecting and
describing these features of their governance models. All
have proved to be valuable for their particular organizations;
the system leaders and our research team hope the readers
of this report also will find them to be useful.

46

Those descriptions are presented in Appendix B:
In alphabetical order by system they include:

Health System

The Governance Feature
They Selected to Describe

Adventist Health System
Sunbelt,
Altamonte Springs, Florida

System Compensation
Philosophy

Ascension Health,
St. Louis, Missouri

Integrated Strategic,
Operational, and Financial Plan

Banner Health,
Phoenix, Arizona

Board Culture

Carolinas HealthCare System,
Charlotte, North Carolina

Competency-Based Board
Selection

Catholic Health East,
Newtown Square,
Pennsylvania

Development of Lay Leaders

Catholic Health Initiatives,
Englewood, Colorado

CHI Discernment Process

Catholic Health Partners,
Cincinnati, Ohio

System Scoreboard and
Executive Evaluation

Christus Health,
Irving, Texas

Generative Governance

Kaiser Foundation Hospitals
and Health Plan,
Oakland, California

Board Committee for
Community Benefit

Mayo Clinic,
Rochester, Minnesota

Building Mayo Clinic’s Vision
for 2020

Mercy Health,
Chesterfield, Missouri

Physician Integration Policy
and Strategy

Providence Health &
Services,
Renton, Washington

Board “Checking In and
Checking Out” Practice

Sutter Health,
Sacramento, California

Restructuring Governance to
Enable Strategic Alignment

Trinity Health,
Novi, Michigan

Founding Principles
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SYSTEM PERFORMANCE

This section of the report addresses two dimensions
of the health systems’ performance: First, their scores
in relation to the indicators of effective governance
addressed in this study; and second, their operating
performance using a Thomson Reuters assessment
protocol that uses a blend of eight measures.

Governance Scores
This study examines board structures, processes, and
cultures in a set of large, nonprofit health systems in
relation to basic benchmarks of effective governance
and related indicators. Table 31 displays the nine
benchmarks, 34 indicators which the research team
considered to be reasonably well-established and
measurable, and the manner in which those indicators
were scored. By meeting all of these indicators, a system
could receive a maximum score of 48.

TABLE 31

Benchmarks and Related Indicators of Effective Governance Against Which the Health
Systems were Scored

Benchmarks and Related Indicators
1

Scoring Basis*

Possible
1 Score

Effective boards insist on governance policies and structures that facilitate their
efforts to perform the board’s functions and fulfill its responsibilities

1.1 Board bylaws establish clear limits on the number of consecutive terms a voting
member may serve

Yes

1

1.2 Board bylaws establish clear limits on the number of voting board members

Yes

1

1.3 Board size is consistent with Blue Ribbon Panel on Health Care Governance
recommendations (9-17 members)

Yes

1

1.4 Standing board committees have clear oversight responsibilities for the following
governance functions:
(a) Audit and compliance
(b) Board education and development
(c) Community benefit
(d) Executive compensation
(e) Finance and investment
(f) Patient care quality and safety
(g) System-wide strategy and planning

Yes
(one point for each
function for which
there is a standing
oversight committee)

7

1.5 The responsibilities of all standing board committees (not just some) are spelled out
in a written document or documents (“charters”) and formally adopted by the health
system board

Yes

1

1.6 The board has an “executive committee” that is authorized to act on behalf of the
full board between its meetings

Yes

1

1.7 Board members perceive their board’s committees to be highly organized and very
effective

Yes

1
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TABLE 31 (continued)

Benchmarks and Related Indicators of Effective Governance Against Which the Health
Systems were Scored

Benchmarks and Related Indicators
2

Possible
1 Score

Effective boards are comprised of highly-dedicated persons who collectively
have the competencies, diversity, and independence that produce constructive,
well-informed deliberations

2.1 Board composition includes at least a majority of voting board members who
are “independent” (i.e., not a member of a sponsoring body such as a religious
community, not a full- or part-time employee, and not directly affiliated with the
system in any way other than serving as a board member)

At least a majority of
voting board members
are independent

1

2.2 Substantial racial diversity in board composition

At or above the median
% of all 14 systems (17%)

1

2.3 Substantial gender diversity in board composition

No objective basis for
scoring at this time

−

2.4 Substantial engagement of voting members have clinical (medical and nursing)
education and experience

At or above the median
% of all 14 systems (20%)

1

3.1 Where the board is accountable to a higher body, there is a formal, written
document that specifies the powers reserved to that body

Yes

1

3.2 Where the board is accountable to a higher body, there are specific, well-established
mechanisms through which the board fulfills its accountability to that body

No objective basis for
scoring at this time

−

3.3 There is a board-approved document that specifies the allocation of responsibility
and authority between the system and local organizations

Yes

1

3.4 The association of responsibility and authority is widely understood and accepted
both by local and system-level leaders

Yes

1

4.1 The board has adopted written descriptions of both the board chair’s and the CEO’s
role and duties

Yes
(both questions)

1

4.2 There is solid agreement among board members and the CEO on the distinctions
between the chair’s and CEO’s role

Yes

1

4.3 The working relationship between the board and the CEO is consistently excellent**

Yes

1

3

4
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Scoring Basis*

Effective boards have clear definitions of their authority and accountability and
the decision-making responsibility they have allocated to local operating units in
their system

Effective boards require mutual understanding regarding the respective roles
of governance vs. management, skillful board leadership, and excellent
board-management relationships

Study Findings

TABLE 31 (continued)

Benchmarks and Related Indicators of Effective Governance Against Which the Health
Systems were Scored

Benchmarks and Related Indicators
5

Scoring Basis*

Possible
1 Score

Effective boards continuously improve board and CEO performance by setting
clear expectations, conducting objective evaluation, and taking follow-up actions

5.1 The board formally evaluates how well it is fulfilling its responsibilities annually or
every other year

Yes, annually or every
other year

1

5.2 During the past two years, the board evaluation process resulted in specific actions
that substantially changed board size, composition, or practices

Yes

1

5.3 Board members believe their board’s current board evaluation process is excellent
and has resulted in substantial improvements in board performance

Yes

1

5.4 CEO’s performance is evaluated in relation to established expectations annually

Yes

1

5.5 CEO evaluation process produces clear performance expectations for the CEO and
assesses their actual performance fairly

Yes

1

Yes, for board and
management positions

2

Yes, for board or
management positions

1

7.1 The board formally adopts system-wide core measures and standards for quality
of patient care

Yes

1

7.2 The system board regularly receives written reports on system-wide and hospitalspecific performance in relation to established measures and standards for the
quality of patient care

Yes

1

7.3 Within the past 12 months, the board has adopted specific action plans
directed at improving the system’s performance in patient care quality
and safety

Yes

1

7.4 The board has adopted a formal written statement that defines overall goals and
guidelines for the system’s community benefit program

Yes

1

6

Effective boards have clear definitions of their authority and accountability and
the decision-making responsibility they have allocated to local operating units in
their system

6.1 The board has adopted formal succession plans for board and senior
management positions

7

Effective boards insist on meetings that are well-organized, focus principally
on system-level strategy and key priorities such as patient care quality and
community benefit, and employ board members’ time and energy wisely
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TABLE 31 (continued)

Benchmarks and Related Indicators of Effective Governance Against Which the Health
Systems were Scored

Benchmarks and Related Indicators

Scoring Basis*

Possible
1 Score

7.5 The board requires its local organizations to collaborate with local public health agencies in
their vicinity in assessing community needs and setting community benefit program priorities

Yes

1

7.6 The board requires its local organizations to develop and adopt a formal community benefit
plan that identifies specific strategies and priorities for its community benefit activities

Yes

1

7.7 Well-organized board meetings focused principally on strategic deliberations, rather
than “receiving information”***

Yes

1

8.1 The board consistently demonstrates a healthy and proactive culture including:
(a) Deep commitment to the system’s mission
(b) Well-organized board meetings focus principally on strategic deliberations,
rather than “receiving information”***
(c) Tracking system’s performance (clinical and financial) and taking action when
performance doesn’t meet targets
(d) Encouraging robust engagement and respectful disagreement at board meetings
(e) Atmosphere of mutual trust among board members
(f) Holding board members to high standards of behavior and performance
(g) Strong focus on honoring Conflict of Interest and Confidentiality policies

Always

7

8.2 The board is actively engaged in discourse and decision-making, with most board
members willing to express their views and constructively challenge each other and
the management team

Yes

1

9.1 The CEO demonstrates strong commitment to board development and on-going
improvement in governance effectiveness

Consensus of the
system’s board members

1

9.2 The working relationship between the board and the CEO is consistently excellent**

Yes

1

9.3 All standing board committees (not just some) are staffed by senior members of
system leadership team

Yes

1

9.4 The board routinely holds an executive session at the end of board meetings without
the CEO and other management staff present

Yes

1

8

9

Effective boards intentionally create a culture that nurtures enlivened
engagement, mutual trust, willingness to act, and high standards of performance

Effective boards expect their CEOs to demonstrate exceptional leadership and
management skills, high personal and professional standards, and strong support
for the role of governance

Total Possible Score

48

*For items where the scoring is based on the opinions of board members and the CEO, there must be at least 80% agreement on a particular response to identify
it as the “system position” on that item. Where only outside board member data is applicable (i.e., excluding the CEO), there must be at least 75% agreement on
a particular response to identify it as the “system position.” To obtain a copy of the Data Collection Guide, send a request to Lawrence Prybil at Lpr224@uky.edu
**This indicator relates to Benchmarks #4 and #9
***This indicator relate to Benchmarks #7 and #8
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Table 32 shows the governance scores for each health
system. They ranged from a high of 42 to a low of 26;
the mean score was 33.9, and the median score was 35.128
Table 33 displays consolidated information about all 14
systems. For each benchmark it shows the number of
scorable indicators, the total possible score a system could
receive, the range of the systems’ actual scores, and — for
the 14 systems as a whole — their collective mean score.
As with each system’s individual scores, this information
demonstrates there is considerable variation in the extent to
which the systems’ board structures, processes, and cultures
collectively meet contemporary benchmarks of effective
governance. On the whole, the systems score high (over
80% of total possible score) on three benchmarks:
• Benchmark #1: “Effective boards insist on
governance policies and structures that facilitate their
efforts to perform the board’s functions and fulfill its
responsibilities.”

TABLE 32

Total Governance Scores for All 14 Systems

System A
System B
System C
System D
System E
System F
System G
System H
System I
System J
System K
System L
System M
System N

Score

% of Total Possible
Points (48)

42
40
39
38
36
36
36
34
31
31
30
28
28
26

88%
83%
81%
79%
75%
75%
75%
71%
65%
65%
63%
58%
58%
54%

Rank
1
2
3
4
5
5
5
8
9
9
11
12
12
14

• Benchmark #4: “Effective boards require mutual
understanding regarding the respective roles of
governance vs. management, skillful board leadership,
and excellent board-management relationships.”
• Benchmark #9: “Effective boards expect their
CEOs to demonstrate exceptional leadership and
management skills, high personal and professional
standards, and strong support for the role of
governance.”
As a group, the systems scores were relatively low (60%
or less of total possible score) on three benchmarks:
• Benchmark #6: “Effective boards are committed
to establishing and continually updating succession
plans for the board, board leadership positions,
and, in concert with the CEO, senior management
positions.”
• Benchmark #7: “Effective boards insist on meetings
that are well-organized, focus principally on systemwide strategy and key priorities such as patient care
quality and community benefit, and employ board
members’ time and energy wisely.”
• Benchmark #8: “Effective boards intentionally
create a culture that nurtures enlivened engagement,
mutual trust, willingness to act, and high standards
of performance.”
Continuous evaluation and improvement is the pathway
to great performance in all endeavors. The systemspecific and consolidated information presented in Tables
32 and 33 shows that all of these excellent health systems
have opportunities to further improve their governance
models and suggests some possible areas that warrant
collective attention.
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TABLE 33

The Systems’ Collective Scores for the Indicators Related to Each Benchmark

Benchmark

52

1

Effective boards insist on governance policies
and structures that facilitate their efforts to
perform the board’s functions and fulfill its
responsibilities

2

No. of Scorable
Total
Indicators Related Possible
to this Benchmark Score

Range of the The Systems’ The Mean as
14 Systems’
Collective
% of Total
Scores
Mean Score Possible Score

7

13

8-13

11.4

88%

Effective boards are comprised of highlydedicated persons who collectively have the
competencies, diversity, and independence
that produce constructive, well-informed
deliberations

3

3

1-3

1.9

63%

3

Effective boards have clear definitions of their
authority and accountability and the decisionmaking responsibility they have allocated to local
operating units in their system

3

3

1-3

2.1

70%

4

Effective boards require mutual understanding
regarding the respective roles of governance
vs. management, skillful board leadership, and
excellent board-management relationships

3

3

0-3

2.5

83%

5

Effective boards continuously improve board and
CEO performance by setting clear expectations,
conducting objective evaluation, and taking
follow-up actions

5

5

2-5

3.4

68%

6

Effective boards are committed to establishing
and continually updating succession plans for
the board, board leadership positions, and,
in concert with the CEO, senior management
positions

1

2

0-2

1.2

60%

7

Effective boards insist on meetings that are
well-organized, focus principally on system-level
strategy and key priorities such as patient care
quality and community benefit, and employ
board members’ time and energy wisely

7

7

2-6

3.8

54%

8

Effective boards intentionally create a culture
that nurtures enlivened engagement, mutual
trust, willingness to act, and high standards of
performance

2

8

0-7

4.3

54%

9

Effective boards expect their CEOs to
demonstrate exceptional leadership and
management skills, high personal and
professional standards, and strong support for
the role of governance

4

4

2-4

3.4

85%

Study Findings

Operating Performance
As Peter Drucker and many other experts have noted
over the years, hospitals and health systems are among
the most complex organizations that exist. A myriad
of inputs contribute to determining the cost, quality
and volume of services they provide for the patients,
populations, and communities they serve.
Other than standard financial indicators, no universallyaccepted methods for assessing the overall performance
of hospitals or multi-unit health systems exist. As the
Medicare Program and other payors move toward “valuebased payment systems” that provide incentives for
excellence in patient care and efficiency in cost control,
major efforts are being made by providers, voluntary
organizations such as the National Quality Forum, the
Centers for Medicare and Medicaid Services (CMS),

and many other parties to develop performance
measurement systems that are fair, practical, and reliable.
This is complex terrain. Lots of time and effort already
have been invested; much more work remains to be done.
Methodologies for measuring the overall performance
of multi-unit health systems are even less developed
than methodologies for measuring the performance
of hospitals, and thoroughly examining the operating
performance of the 14 large systems in this population
is beyond the scope of this study. However, as one
indicator of the performance of the systems’ hospitals,
the team obtained the results of a 2012 study conducted
by Thomson Reuters.129 That study examined the
performance of private and investor-owned health
systems using a combination of eight patient care
measures. These measures and sources of data are
shown in Table 34.130

TABLE 34

Performance Measures and Data Sources for 2012 Thomson Reuters Health System
Performance Study

Measure

Data Source and Time Period

Risk-adjusted mortality index

MedPAR FY2009 and 2010

Risk-adjusted complications index

MedPAR FY2009 and 2010

Risk-adjusted patient safety index

MedPAR FY 2009 and 2010

Core measures mean percent

CMS Hospital Compare, second quarter 2011 release (October 1,
2009-September 30, 2010 dataset)

30-day mortality rates (AMI, heart failure, pneumonia)

CMS Hospital Compare, second quarter 2011 release (July 1, 2007June 30, 2010 dataset)

30-day readmission rates (AMI, heart failure, pneumonia)

CMS Hospital Compare, second quarter 2011 release (July 1, 2007June 30, 2010 dataset)

Severity-adjusted average length of stay

MedPAR FY 2010

HCAHPS score

CMS Hospital Compare, second quarter 2011 release (October 1,
2009-September 30, 2010 dataset)
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Of the 83 health systems with over $1.5 billion in
operating expenses in 2010, 71 were independent,
nonprofit organizations. Thomson Reuters was able
to obtain data for 13 of the 14 systems in this study
population. Based on their composite scores on the eight
measures outlined in Table 34, the rankings of these 13
systems among the total group of 71 large, nonprofit
systems ranged from a high of Number 2 to a low of
Number 52. The median rank of the 13 systems was 28.
On this set of measures, the health systems in this study
population on the whole perform well in comparison to
other large nonprofit systems.

Governance Impact of Organizational
Performance131
In recent years there have been graphic illustrations
of the adverse impact that ineffective governance can
have on organizations. Inadequate board direction
and/or oversight have been factors in major problems
encountered by numerous organizations such as
Allegheny Health, Education, and Research Foundation
(AHERF), Enron, HealthSouth, Merrill Lynch, British
Petroleum, and, recently, J.P. Morgan Chase.132
In these and other situations, poor governance has been
shown to contribute substantially to poor organizational
performance and, in some instances, abject failure.
Common sense would suggest the inverse also should
be true, i.e., that effective governance should contribute
in some degree to organizational success. Examining
this thesis is complicated by many factors including
the myriad of variables, both internal and external, that
affect organizational operations and the difficulty of
defining and measuring “organizational performance”
in a consistent, meaningful, and valid manner. This is
especially difficult in nonprofit healthcare organizations
for which classic financial performance measures are
important but not sufficient and patient care outcomes
and impact on community health are paramount.
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The historical evidence of governance impact on
organizational performance in various sectors is mixed.133
However, a growing body of empirical studies supports
the general proposition that, in the long term, there is a
positive relationship between the caliber of governance
and organizational success.134
This study of governance in large, nonprofit health
systems was not designed to determine the impact of their
boards’ structures, processes, and cultures on the systems’
operating performance. The size of the population (14
of the country’s 15 largest nonprofit health systems based
on 2010 information) is not sufficient to enable robust
analysis of this complex topic and, as stated earlier, there
are no universally-accepted methods for measuring the
overall performance of health systems including their
financial, patient care, and community service results.
While recognizing and respecting these constraints,
the research team did explore the relationships between
the systems’ scores on the benchmarks of effective
governance and related indicators shown in Tables
31-33 and their performance scores on the performance
measures listed in Table 34. This analysis did not find a
statistically significant correlation between the systems’
total governance scores displayed in Table 32 and their
aggregate scores on the eight patient care measures
included in the Thomson Reuters study. Positive and
statistically significant correlations between the systems’
total governance scores and some individual patient
care measures were identified. These data are not
sufficiently meaningful or statistically robust to warrant
solid conclusions; however, they underscore the need for
further examination regarding the long-term effect of
governance on organizational performance — and, thus,
steps that can be taken to ensure that impact is positive.

IV. Concluding Remarks and Recommendations

As stated in Section I, the purpose of this study is to
examine board structures, processes, and cultures in a set of
our country’s largest nonprofit health systems and compare
them to several benchmarks of effective governance and
related indicators. The objectives of the study are to:
• Increase our understanding of governance in large
health systems;
• Identify and describe some examples of “exceptional
governance features” that are in place in these systems;
• Identify areas where, on the whole, the governance of
these systems could be improved; and
• Produce information that can assist CEOs and board
leaders — in these systems and other healthcare
organizations — to assess and enhance their boards’
effectiveness.
These are turbulent and challenging times for those with
leadership roles in hospitals, health systems, and other
healthcare organizations. For many reasons, the need for
healthcare services is growing and resource constraints
are becoming more stringent. Clinical, executive, and
governance leaders are being asked by public and private
payors and many stakeholders to improve access, quality,
and operational efficiency in ways that can be measured and
documented. In the near future, “value-based” purchasing
programs of various forms are likely to predominate, and
payment methods will be evidence-based with increasingly
stringent standards and requirements. Hospitals and
health systems increasingly will be expected to focus on
preventing illness and injuries and improving the health of
the communities and populations they serve.
In this environment, the duties of governing boards have
become more complex and demanding. In recent years,
organizations with oversight responsibilities for nonprofit,
tax-exempt hospitals and health systems — including
bond rating agencies, the IRS, the Joint Commission,
the Office of the Inspector General, and others — have
focused increasing attention on governing boards.
With varying degrees of rigor and specificity, they are
expecting distinct improvements in board performance,
transparency, and accountability.

The process of formulating the nine benchmarks of
effective governance and related indicators addressed
in this study considered these expectations as well
as information from other sectors. The findings of
this study provide solid evidence that the boards and
CEOs of the systems in this study population are
highly committed to the organizations they lead and
dedicated to improving governance and organizational
performance. However, the findings clearly show
some gaps between current practices and contemporary
benchmarks of effective governance. A number of other
studies regarding governance in hospitals and health
systems cited in this report reach similar conclusions.
To meet society’s increasing needs and rising expectations,
it is apparent that substantial changes will be required
in healthcare organizations and how they are governed.
Therefore, the team recommends that board leaders and
CEOs of nonprofit health systems and other healthcare
organizations:
1. Conduct an overall review of their board’s role and
responsibilities in the context of recent and anticipated
changes in the healthcare environment and in the
communities they serve. They must ensure all board
members clearly understand the impact of these changes
on their individual and collective duties.
The 14 health systems that participated in this study are
progressive and, as one illustration, their boards clearly have
made deliberate efforts to increase the energy and time they
devote to strategic deliberations and decision-making. All
of these boards are in the midst of reforming their board
agendas and practices in this direction while still providing
proper oversight of system operations and performance.
However, the findings indicate that even this group of
boards and their CEOs believe they must continue and
accelerate the shift toward a greater focus on systemwide strategy and strategic thinking. Evidence from
other studies in the healthcare field and other sectors
suggest many boards still spend large portions of board
meetings listening to reports and discussing operational
issues as compared to active engagement in constructive
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dialogue about strategic challenges and opportunities.
Therefore, the team recommends that board leaders and
CEOs of nonprofit health systems and other healthcare
organizations:
2. Candidly re-examine their board and board committee
agendas and practices, with a focus on how the meetings
are structured, how topics are selected, expectations
regarding the distribution and review of materials in
advance of meetings, and pragmatic steps that can and
should be taken to enable the board to devote more time
and energy to strategic deliberations. The effectiveness
of changes that are made should be evaluated on an
on-going basis with strong commitment to continual
improvement.
Achieving excellence in any endeavor requires
commitment to on-going evaluation and improvement.
Particularly in a dynamic environment, forthright
assessment and timely changes are essential to
organizational survival and success. Evidence from many
studies indicate that board evaluations often become a
formality, a pro forma exercise that involves completing
standard questionnaires and leads to reports that are
accepted with little deliberation and produce little or no
action. This is an approach that wastes time, perpetuates
the status quo, and does not improve board structures,
practices, culture, or performance. Therefore, the team
recommends that board leaders and CEOs of nonprofit
health systems and other healthcare organizations:
3. Engage in a thorough assessment of their existing
“board evaluation” processes and practices with the
intent of either improving them or, depending on
the findings, totally replacing them with better, more
progressive models. The goal is to have vibrant,
outcome-oriented evaluation processes — formal
and informal — that consistently generate action and
improve the effectiveness of boards, board committees,
and board leadership. Retaining expert, independent
parties to facilitate the re-examination of current board
evaluation protocols may be helpful in this initiative.
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Societal realities are demanding fundamental changes
in the mission and goals of public and private health
organizations and the services they provide to their
communities. Stakeholders want assurance that nonprofit
hospitals and health systems deserve tax-exempt status
and are meeting high-priority community needs and that
public health agencies are performing essential functions
efficiently and effectively. Concurrently, the historic roles
of hospitals and health systems and public health agencies
are evolving as all parties recognize that prevention of
illness and injuries, early detection and treatment, and
intentional promotion of wellness in all sectors of the
population are imperative. Better communication and
closer collaboration among health systems and public
health agencies increasingly are essential. Therefore, if
they haven’t already done so, the team recommends that
board leaders and CEOs of nonprofit health systems and
other healthcare organizations:
4. Charge a standing board committee with oversight
responsibility for system-wide community benefit
policies and programs and the organization’s role and
priorities in the realm of population health. It is time for
a fresh look at traditional practices and relationships —
and for new approaches that will serve our communities
better and more efficiently.
The idea of building stronger, more durable linkages
between the private and public sectors of the health field
and instituting new models for promoting population
health has important implications for traditional practices
in both sectors. Among them are the need to re-think
the organizations’ fundamental roles and accountabilities.
It has been customary for many nonprofit hospitals and
health systems to declare a principal accountability to the
“community or communities they serve.” This clearly
is appropriate; however, the mechanisms, methods, and
metrics for fulfilling that accountability often are underdeveloped and imprecise. In an era where governmental
bodies with regulatory and/or oversight responsibilities
and society at-large are scrutinizing nonprofit
organizations more closely than ever before, the question
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of these organizations’ accountability — to whom, for
what, and how it can be fulfilled effectively — warrants
attention. Therefore, the team recommends that board
leaders and CEOs of nonprofit health systems and other
healthcare organizations:
5. Collaborate with professional associations and legal
experts in developing better methods and practices to
enable their organizations to be properly accountable
to the communities and populations they are chartered
to serve. This process can and should be open to
new definitions and protocols that provide greater
transparency and new metrics.
Strong, effective oversight of patient care quality and
safety is, without question, one of the most fundamental
duties of hospital and health system boards. Among
clinical, governance, and management leaders, there now
is broad recognition that the overall quality of services
provided by our country’s hospitals and health systems is
uneven and needs to be improved. During recent years,
this realization — coupled with the movement toward
evidence-based medicine and value-based purchasing
programs — has produced enormous growth in quality
improvement programs and metrics. This trend is
important and necessary; however, one consequence
is that hospital and health system boards often are
presented with reports on patient care quality and safety
that include an extensive array of highly-detailed metrics
and data that, for many board members (including
executives and clinicians) are too voluminous and difficult
to comprehend.
The boards and CEOs of the large systems in this study
population clearly are focused on meeting their oversight
responsibilities with respect to patient care quality and
safety. However, along with their counterparts in other
health systems, they would benefit from improvements
in the content and form of information they receive
as the basis for deliberation. Too many boardrooms
are awash in quality and safety “data”; what the boards
need is more concise and understandable information.

Therefore, the team recommends that board leaders and
CEOs of nonprofit health systems and other healthcare
organizations:
6. Mount concerted initiatives — in partnership with
their clinical leadership teams, other health systems,
voluntary associations, and independent experts in
this area — to define more clearly the roles that boards
and board committees can and should play in today’s
environment with respect to patient care quality and
safety. In that context, the information (volume,
content, and format) that will facilitate board members’
understanding and ability to perform their duties
effectively should be identified and provided.135
A large proportion of the board leaders and CEOs in
the health systems in this study population recognize the
tremendous importance of thoughtful, well-organized
leadership succession planning programs for boards,
board leadership positions, and system management
positions. Most of these systems already have some
type of succession planning programs in place — and,
thus, appear to be somewhat ahead of most healthcare
organizations. However, nearly all of these board leaders
and CEOs view their present programs as “work-inprogress” that need further development. Therefore,
the team recommends that board leaders and CEOs
of nonprofit health systems and other healthcare
organizations:
7. Make the development of top-notch leadership
succession planning programs for boards, board
leadership, and senior management a systemwide strategic priority. The basic components of
comprehensive succession planning programs are
identified in Section III of this report.
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In the healthcare field and other sectors, there is growing
evidence that boards with a culture that consistently
demonstrates commitment to high standards, mutual trust
among board members and management leadership, robust
engagement in the work of the board, and willingness
to take action are more likely to perform well than other
boards. As stated recently by Pamela Krecht and Karma
Bass, “A healthy culture at the very top of an organization
can create a spillover effect to the organization as a whole.
With all the changes facing [healthcare] organizations
today, a healthy culture can be a key differentiator in
facilitating an organization’s success.”136
The findings of this study show the system boards and
CEOs are highly committed to their organization and
its mission. However, with respect to several other core
characteristics of a healthy culture, many senior board
leaders and CEOs perceive their boardroom cultures
as uneven.

For these boards — and the boards of most other
healthcare organizations — frank, objective appraisal
of their existing boardroom culture is likely to identify
practical steps that, if taken, will strengthen the culture
and, in doing so, improve the board’s performance.
Therefore, the team recommends that board leaders
and CEOs of nonprofit health systems and other
organizations:
8. Undertake an objective appraisal of the boardroom
culture that currently prevails within their organization
and determine steps that can be and should be taken to
make it healthier and more effective.
It is the team’s belief that these eight recommendations
are evidence-based and warrant consideration by the
systems that participated in this study and by other
healthcare organizations. It is our view that devoting
some time and energy to considering them will prove to
be a good investment that will pay long-term dividends
for each board, the organization it governs, and the
population and communities it serves.
After some consideration and reflection, it is paramount
for boards to identify and prioritize the particular issues
they believe are most important, assign responsibility,
and set a timetable for taking action. Focusing on
carefully-established priorities will enable prudent use of
board and staff time and increase the likelihood of solid
improvement in board practices and performance.
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Appendix A – Limitations of the Study

The methodology employed in this study has several
limitations. They include:
• The study population was limited to 14 of the
country’s 15 largest private, nonprofit health systems
in 2010 using AHA data and a blend of three
measures of size: total annual operating expenses for
the system’s hospitals, the number of hospitals in the
system, and the number of counties in which those
facilities are located. The findings and conclusions
relate directly to exceptionally large, nonprofit
systems; they cannot be generalized to systems of all
types and sizes.
• The study has focused on comparing board structures,
processes, and cultures in a set of very large health
systems to nine benchmarks of effective governance and
34 related indicators. These benchmarks are pertinent
to the governance of large systems, and the indicators
are considered to be reasonably well-established and
measurable. There certainly are other benchmarks that
merit attention by CEOs and board leaders but, due to
constraints including the unavailability of measurable
metrics and/or objective scoring techniques, these are not
addressed in this study.

• The tests employed in this report to determine
the statistical significance of observed differences
(chi-square test, two-sample test of binomial
proportions, and Fisher’s exact test) and correlations
(Pearson’s product-moment and Spearman’s rank
correlation coefficient) are appropriate for this data
set. However, due to the relatively small size of the
study population, some of the testing procedures
do not have sufficient power to detect and precisely
estimate actual differences and correlations.
• This study examined certain aspects of board
structures, processes, and cultures in a set of large
nonprofit health systems and compared them
to nine benchmarks of effective governance and
related indicators. Clearly there is great need
and opportunity for more research regarding the
governance of both nonprofit and investor-owned
healthcare organizations. As one example, we would
encourage studies designed specifically to examine
relationships between selected features of board
structures, processes, and cultures and measures
of organizational performance.

• This report presents the views of system CEOs and
board members regarding their particular board’s
structure, selected processes and practices, and
cultures. A structured interview guide was employed,
and there were substantial follow-up communications
after the site visits to clarify questions and obtain any
missing data elements. Also, information obtained
from system documents and staff members were
employed to supplement and, where possible, verify
the interview data. However, those data represent
the participants’ perceptions and may or may not be
factually correct in some instances. Opinion data
have inherent limitations, and there are bound to be
some inaccuracies in the team’s interpretation and
summarization of those data.
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Appendix B – Selected Features of the Participating Systems’
Governance Models

Adventist Health System
Altamonte Springs, Florida

Compensation Philosophy
The current philosophy of Adventist Health System in compensation dates from the mid 1990’s. Prior to that time,
our system did not even use a market-based approach, but had an extremely conservative wage structure tied to some
Church approved principles.
When it was agreed the time had come to adopt a market-based approach, our System’s governance and management
leadership team was determined to have a program that met all of the requirements that could be expected of a
501(c)3 organization, but also wanted the philosophy, while market-based, to be conservative. Attachment A is a
statement of our System’s Board-approved compensation philosophy.
Also, governance and management leadership decided the Compensation Committee should take actions that would
generate confidence in and support for the compensation system by establishing processes and procedures that went
beyond the IRS standards for obtaining the rebuttable presumption of reasonableness.
A governance practice we started at the time, and even up to the current day has never been required by external
parties, is to have the System’s external auditor annually review the actual implementation of the compensation
program to ensure management has carried out the instructions of the Compensation Committee without exception.
That practice has now been in place for several years. To date there has never been an instance where a compensation
action has been out of line with the Committee’s instructions or a variance that was inconsistent with the authority
given by the Committee to the CEO of the company.
The fact that the actual administration of wage and benefit practices is independently audited, we believe is, a very
beneficial practice that may not be employed by some health systems. It gives our Board and its Compensation
Committee additional comfort and protection and, in addition, protects management from any chance of being
criticized for doing something which is not authorized by the Compensation Committee.

Donald Jernigan, Ph.D.
President and CEO, Adventist Health System
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• Small hospitals may exceed the 50 percentile as necessary.
• Geographic adjustments may be approved where necessary.
Other compensation:
• Flex Benefit percent at market median
Appendix
B
• Incentive
bonus opportunity at market median for the respective position
4. COMPENSATION PROCESS
•

The committee will select their Advisor from qualified professionals who specialize in healthcare
2
Attachment A
executive compensation. The Committee shall provide direction to the Advisor with regard to
AHS compensation philosophy and practices which will form the basis for a compensation study
and then commission the review of all executive wage ranges, benefit and bonus levels by their
Advisor.
• The compensation study for all AHS executive positions will be performed every other year.
• Once the study is completed, the Advisor shall submit an advance report to the committee chair
for review.
• The Committee chair shall review the proposed ranges for compliance with AHS and North
American Division Guidelines as identified in “compensation standards” above.
• The AHS CEO will provide recommendations to the Committee for each executive’s salary for
the ensuing year.
• The Committee will receive the CEO’s recommendation, approve accordingly and establish a
date for implementing the new base salaries.
• For years when a full wage study is not performed, the Committee shall approve an annual
adjustment to base salary based upon a report from the Advisor.
• Individual studies will be performed for new positions as needed. Individual studies will also be
performed, as they are needed, for positions where major changes in responsibilities have
occurred.
• In addition to reviewing and approving new base salaries, the Committee will annually approve
the Accountability program performance objectives and the awarding of incentive payments.
• As necessary, the Committee will review and approve any changes to the executive Flex Benefit
SIGNATURE NEEDED? SEE WORD DOC
and Accountability plans.
The Chair of the Committee will report committee actions to the full board.

Approved: April 2000
Affirmed: December 5, 2007
Revised: September 17, 2009
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Ascension Health
St. Louis, Missouri

4/12/2012
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Partnerships, Empowering Knowledge and a Vital Presence in meeting the evolving needs of the communities
In their annual Integrated Strategic, Operational and Financial Plans (ISOFP), each of Ascension Health’s
In their annual Integrated Strategic, Operational and Financial Plans (ISOFP), each of Ascension Health’s Health
Health Ministries describes their strategic, operational, financial and capital plans and highlights their
Ministries describes their strategic, operational, financial and capital plans and highlights their current and planned
current and planned participation in the components of Ascension Health’s Strategic Direction over a
participation in the components of Ascension Health’s Strategic Direction over a five-year period. The ISOFP
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Current Work / Initiative
Create an Exceptional Patient Experience
Implement Physician Engagement Strategies
Build Community Coalitions that Address Public Health
Issues (e.g., childhood obesity)
Implement Initiatives to Optimize Associate Health
Forge Partnerships With Post‐Acute Care Providers
Deploy Electronic Health Records
Develop Unique Health Services for Seniors

Fit with Strategic Direction Component
Healthcare That Works
Healthcare That Is Safe
Healthcare That Leaves No One Behind
Model Community
Trusted Partnerships
Empowering Knowledge
Vital Presence
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Strategic relevance is the ability to pursue strategies that ensure accomplishment of the
Strategic Direction, appropriate services are provided by the Health Ministry or in partnership
65

4

Appendix B

Strategic relevance is the ability to pursue strategies that ensure accomplishment of the Strategic Direction, appropriate
services are provided by the Health Ministry or in partnership with others, programmatic development is relevant to the
current and future needs of the communities served and a vital presence is maintained in the community.
Stewardship of the Mission and its long-term preservation calls each Health Ministry to be operationally excellent and
ensure that high quality, safe clinical services are provided in the most efficient manner, productivity is maintained at or
better than benchmark levels and high-value support services are provided to operations.
Financial health is the ability of leadership to optimize Health Ministry financial performance to fund care for
persons who are poor and vulnerable, short-term capital needs, replacement of the long-term assets, sufficient resources
for programmatic development, resources for investing in transformational opportunities and resources during economic
downturns.
Ascension Health’s Ministry Market Leaders1 assume shared accountability for assessing the strategies and quality of the
ISOFPs and hold review meetings with each of the Health Ministries in their market prior to ISOFP submission to the
System Office. The objectives of these meetings are to:
1.
2.
3.
4.

Confirm that the ISOFP was developed with a high level of rigor.
Assess the level of collaboration between finance, operations and strategy leaders.
Validate that mechanisms are in place to monitor ISOFP progress and close gaps in performance.
Ensure that Health Ministry leaders are committed to the achievement of the ISOFP.

The consolidated System ISOFP is eventually presented to the Ascension Health Board Finance Committee and
full Board of Trustees each June for approval and serves as a key input to Ascension Health’s Developmental Model
(Attachment A) which supports the tracking of Strategic Direction initiatives from early development to full operations.
Ascension Health’s senior leaders and Board of Trustees also utilize an Integrated Scorecard to set annual goals, align
incentives and measure the progress that each Health Ministry is making in delivering on the System’s Strategic Direction
commitments.

Anthony R. Tersigni, Ed.D.
President and CEO, Ascension Health Alliance

1

Ascension Health’s Health Ministries are organized into eight regional Ministry Markets (e.g., New York/Connecticut, Gulf Coast/North
Florida). Each Ministry Market is led by an executive, the Ministry Market Leader.

66

Ascension Health’s Strategic Direction

Appendix B
1

Ascension Health’s Health Ministries are organized into eight regional Ministry Markets (e.g., New York/Connecticut, Gulf Coast/North
Florida). Each Ministry Market is led by an executive, the Ministry Market Leader.

Executive Compensation Philosophy and Practices

Ascension Health’s Strategic Direction
1. COMPENSATION PHILOSOPHY

The compensation philosophy of Adventist Health System (AHS) rests on two fundamental beliefs. First,
the primary motivation of professionals who choose to join AHS is not financial but the realization of
mission. AHS intentionally recruits executive leaders who choose to devote their professional and
personal skills to advance the medical ministry of the Seventh-day Adventist Church (SDA). Because
executives believe themselves to be agents of the church’s medical ministry, wages are more
conservative by market standards. Second, the demand for highly competent and experienced SDA
healthcare executives makes it necessary for AHS, working with the support of church leadership, to set
wages at market levels. These market levels will be based on principles and guidelines which have met
standards of the AHS board officers and the North American Division of SDA.
2. ROLE OF BOARD STRATEGY AND COMPENSATION COMMITTEE

Intensity of Resources

The role of the Board Strategy and Compensation Committee (Committee) is to review and approve all
Ascension Health’s Developmental Model
components of the executive compensation plan and to assure that the guidelines and principles agreed
upon with the church will be incorporated in the compensation plan.
3. COMPENSATION STANDARDS
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• The AHS CEO base salary shall not exceed the 40 percentile of comparable CEO positions
nationwide.
• Other leadership base salary shall relate to the 50th percentile of national market data.
• Small hospitals may exceed the 50th percentile as necessary.
• Geographic adjustments may be approved where necessary.
Other compensation:
• Flex Benefit percent at market median
• Incentive bonus opportunity at market median for the respective position
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Banner Health
Phoenix, Arizona

Culture Trumps All Other Variables
for Success
The success of the Banner governance model really focuses on a few key behavioral approaches that have driven
organizational success and demonstrate that culture supports behaviors which drive organizational performance.
First, it has become clear that our operating company model, both at a management level and at a governance level,
is quite complementary. The focus is on a willingness to challenge conventional truths and each other fearlessly
without making the issue personal. This has allowed the board to feel a sense of freedom in debating and considering
those organizational variables associated with long term success as it relates to strategy, financial stability and clinical
performance — both with the management team and with themselves. This has created a safe environment to
engage and has created clarity around what is a management responsibility and what is a governance responsibility.
This clarity of role and responsibility has maximized the use of skills. Banner Health’s “2020 Vision” is depicted in
Attachment A.
Second, while Banner Health was originally created by consolidating two previously separate organizations, the
company was designed and built in a manner that left no opportunity in the future to deconstruct. That forced a focus
on future success and viability rather than old traditions and past loyalties. Therefore from a behavioral perspective,
the desire or need to maintain a constituency behavior model disappeared. It has enabled system leaders to recognize
they are here to create a new company and lead it rather than defend the wishes and desires of past constituencies.
The original board, which was created in September 1999 when the organizations came together, was made up of
several members from each of the prior organizations (Samaritan Health System and Lutheran Health System) and
they jointly recruited a fifteenth member from outside of their respective organizations.
Third, the board developed a behavior that calmly considers difficult issues thoughtfully and candidly. This enables
them to confront issues quickly without emotion but with logic. It also creates an environment that limits things
from going unsaid and creates a healthy, engaged and productive culture.
Fourth, the structure of board meetings has created a behavior that emphasizes focus and preparedness. The board
meets four times a year and the meetings span 2-3 days. Because of this concentrated time period and the fact that
the committee meetings occur in the early part of the 2-3 day meetings, there is no opportunity for relaxation time.
The days are very packed which requires board activities to be focused. As a result, if someone is not well-prepared
ahead of time, there is little opportunity to catch up during the educational program, committee meeting, or full
board meeting. As a result, board members are highly engaged and participate actively.
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Organizational success starts with the Board and the members’ ability to work together in an efficient and effective
manner focusing the organization on key critical success factors. By doing that properly, management will stay
focused on what they do best and the Board will stay focused on what it does best — and, at the same time, making
sure that they are meeting all of their fiduciary responsibilities and guiding the organization forward. As stated by
Mr. Wilford Cardon, long-time Board chair:
“The Banner Board is successful because no board member represents a particular constituency which allows us to
openly debate without fear of reprisal. We disagree without being disagreeable. We encourage differing opinions
defended with facts. However, because the Board understands that the only authority of the Board is in our collective
decision not in our individual opinions, after a robust discussion and a vote, we all coalesce around the collective
decision of the Board and unite with management to implement our collective decision in support of our mission.”

Peter Fine
President and CEO, Banner Health
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Carolinas HealthCare System
Charlotte, N.C.

Competency-Based Board Selection
The board of commissioners of Carolinas HealthCare System (“CHS”) uses a competency-based board selection
process and a robust system for continuing education to build and maintain a stable, high-functioning board. The
board devotes substantial effort to identifying potential candidates for board membership and clearly articulates
to each candidate that the board considers board membership to be a long-term commitment on both sides. This
dedicated focus on board development and succession planning has been consistent for decades.
The process for selection as a member of the board starts with the ongoing review of the collective competencies
of the board and an examination of what competencies should be developed or supplemented. The nominating
and governance committee (the “committee”) looks to identify and recommend potential board members who will
contribute to the mix of skills of the board and who will approach board service as a long-term commitment. The
committee evaluates each prospective nominee’s demonstrated interest in the health and welfare of the general
public, strength of character, mature judgment and relevant technical skills. Further, the committee considers the
performance of incumbents in determining whether to nominate them for re-election or re-appointment. The
practice of approaching board development with a view to the long-term is a major factor in the stability and
quality of the CHS board. At its last regularly scheduled meeting of each year, the board receives and acts upon the
committee’s recommendations for a new class of commissioners to replace those whose terms will expire at the end
of the year.
In addition to having a board of commissioners, CHS has a board of advisors that advises the CEO, the chairman,
and the board of commissioners concerning matters relating to CHS’s facilities. Members of the board of advisors
are appointed by the chairman of the board of commissioners, based on recommendations from the nominating
and governance committee, and from residents of communities served by CHS who have demonstrated an interest
in the health and welfare of the general public. In some respects, the board of advisors serves as a training ground
for potential members of the board of commissioners. The board of advisors meets concurrently with the board of
commissioners and members of the board of advisors participate with members of the board of commissioners on
board committees and board educational sessions and conferences. This structure affords members of the board of
advisors an outstanding “on-the-job” opportunity to learn about CHS and the healthcare sector prior to joining the
board of commissioners.
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The board utilizes a robust committee structure that allows board members and management to devote appropriate
time to explore together specific areas where board oversight is desirable; e.g., strategic planning committee;
finance and compliance committee; and quality care and comfort committee. The board attempts to rotate board
members among the several committees over time, taking into account individual board member preferences and
each committee’s needs. In other words, a board member might serve several years on the quality care and comfort
committee and then rotate off that committee to spend several years on the finance and compliance committee.
Board members may also serve on more than one committee simultaneously depending upon expertise, interest and
time available. This practice of rotating board members among the board committees provides board members the
opportunity to learn more about specific areas of the organization and to develop, over time, a comprehensive picture
of the organization.
The CHS board of commissioners relies on thoughtful, intentional selection of board candidates, utilization of a
board of advisors and an organized approach to board committee service to build and maintain an excellent governing
board. These structures and practices have helped CHS enjoy stability, clinical excellence and financial strength.

Michael C. Tarwater, FACHE
President and CEO, Carolinas HealthCare System
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Catholic Health East
Newtown Square, Penn.

Development of Lay Leaders
in Catholic Healthcare
Like most Catholic health care organizations nationwide, Catholic Health East (CHE) has been focused for some
time on ministry formation - the grounding and development of lay leaders in the healing ministry of Jesus Christ
and the foundations of Catholic health care – in order to secure the future leaders of our organizations.
Following a fairly recent CEO transition and newly appointed Senior Leadership Team, all of whom were internal
candidates, it became apparent that an entire new bench of lay leaders would need to be developed for senior-level
management positions across the system. To help make this happen, leadership development became a top priority
for the organization. This function transitioned from the human resources department to the president’s office, and
gained both board and CEO level sponsorship of a sustained focus on succession planning.
Building on foundational ministry formation work that was firmly established in the organization, it was decided that
integrating ministry formation, classic leadership development and succession planning efforts would expedite building
the needed leadership bench strength. To achieve this integration, the CHE Ministry Leadership Academy was
established. Its purpose is to:
• Continue the development a cadre of committed well-formed lay leaders into servant leaders who are
transformative stewards of their health care ministries – the “sweet” spot where ministry, transformational
and operational leadership overlap, and
• Facilitate smooth succession of Regional Health Care Corporation (RHC) CEOs and CHE-level senior
management teams positions in the near-term future.
The curriculum framework is predicated on integrating three forms of leadership (see Attachment A), which are
expressed in three learning objectives:
1. Ministry Leadership – integrate the core elements of ministry formation into policies, structures and the
organization’s culture so that Catholic identity explicitly informs the work of the ministry and directs its daily
operations.
2. Transformational Leadership – establish leadership capabilities essential to a ministry’s ongoing agility, innovation
and growth.
3. Operational Leadership – determine how to define, align and integrate core functions effectively throughout the
organization.
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The first cohort is comprised of 20 individuals who have been identified as “top talent”, either as part of our annual
talent review process or strongly recommended by local leadership. Top talent is defined as individuals who currently
exceed expectations in terms of the CHE Leadership Competencies, CHE Core Values and performance at the
RHC-level. They act like leaders and demonstrate the capability of advancing to a significantly broader or more
complex role within the next two to three years. Participants were also required to have actively participated in and
completed Excellence in Ministry - CHE’s executive-level ministry formation program. Lastly, they needed to have
a track record of leadership effectiveness and career aspirations consistent with CHE’s organizational and strategic
needs. Each cohort’s engagement is two years in duration. The current plan is to form three cohorts which will
provide us 50 “ministry-ready” leaders within the next five years.
Catholic Health East established a partnership with Seton Hall University to develop and deliver the program. Seton
Hall is providing faculty from their Institute of Catholic Studies and Schools of Theology, Healthcare Sciences,
Theology, Business & Law. We also involve adjunct faculty from other notable institutions and organizations. Because
of the affiliation with Seton Hall, participants earn a leadership certificate upon completion that will be recognized in
the broader Catholic community.
The design is highly interactive, and responsive to current organizational challenges and opportunities. The established
expertise of the academy participants is actively incorporated while simultaneously encouraging them to deepen their
understanding of the essence of Catholic health care and how it should influence their leadership identity. The faculty
sit with the participants and all share responsibility for the learning environment and the content. “Real” organizational
work is brought into the various learning platforms — classroom sessions, exposure opportunities, inter-organizational
rotations and inter-session contacts — in an Action Learning approach. This ensures the learning occurs in the context
of real-life issues and situations and advances the “real” work of the organization at the same time.
Prior to inviting an individual into the Academy, there are conversations confirming his/her career aspirations,
identifying the specific CHE position(s) they will be prepared for during their Academy experience and an individual
development plan is outlined that specifies everything required to ensure their readiness upon completion. Review of the
Academy’s content and the participant’s growth is a standing agenda item for the Board’s Leadership & Compensation
Committee. We also will measure the Academy impact by the number of “ministry-ready” individuals who are available
to fill key positions when we need them, as well as the degree to which the participants can articulate how they have
internalized and evolved into servant leaders who are transformative stewards of their health care ministries.

Judith Persichilli
President and CEO, Catholic Health East
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CHE Ministry Leadership Academy
Curriculum Framework

Ministry Leadership
Transformational Leadership
Participants will strengthen the
transformational leadership skills
essential to their ministry’s
ongoing agility, innovation and
growth.

To create servant
leaders who are
transformative
stewards of their
healthcare
ministries

Participants will strategize how to
integrate the core elements of
ministry leadership into policies,
structures and organizational culture
so that Catholic Identity explicitly
informs our ministry’s life and
directs its daily operations.

Operational Leadership
Participants will acquire an in-depth
understanding and increased capability
with operational leadership – how to
define, align and integrate core functions
effectively throughout the organization.
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Catholic Health Initiatives
Englewood, Colorado

The Catholic Health Initiatives
Discernment Process
Leading and governing Catholic health care ministries call us to balance key principles and values as we make critical
decisions in the best interests of those we serve.
Catholic Health Initiatives has developed a comprehensive discernment process to guide leaders and boards
in making crucial operational and strategic decisions (Attachment A). The Catholic Health Initiatives (CHI)
Discernment Process focuses on the questions, “What is God calling us to do in light of our mission, vision and
core values?” “How do our decisions best translate our ministry into the future?” Discernment respects the presence
of God’s Spirit and creates an environment conducive for the Spirit to act among us. It empowers participants to
speak their truth courageously, in deep reverence for each person; listen attentively to the perspective of those whose
viewpoints may differ from their own; and open their hearts carefully to hear God’s deepest wisdom in the voices
of those around the table.
The CHI Discernment Process is rooted in a values-based decision-making process that guided the health system
through its first decade of development. While many of the steps in the discernment process are found in other
significant business decision-making models, CHI’s process is distinctive in how it incorporates prayer and quiet
reflection at key intervals throughout the process, and how it guides participants to reach, implement and evaluate
decisions based on the system’s mission and core values. The process calls for careful consideration of who will be
impacted by the decision and who will own the decision. It acknowledges the potential conflict among competing
values and engages participants in identifying what values are affirmed and negated in potential actions.
The CHI Discernment Process begins with focused prayer and guides participants to analyze a situation by
defining the issue thoroughly, framing different perspectives and implications, and identifying and weighing possible
alternatives. The process guides participants to reach a resolution based on balancing core values and how the decision
will uphold the system’s mission and vision. Once the decision is reached, the process calls participants to define how
the decision will be implemented, communicated and evaluated.
The CHI Discernment Process provides a comprehensive, consistent framework to evaluate strategic and operational
actions in light of the system’s mission, core values and ethics. Every leader in CHI reviews and practices the
discernment process at a leadership orientation session. Board members at national and local levels across the system
are also introduced to the process during their orientation sessions. It is expected that the CHI Discernment Process
is used for making critical decisions that impact the ministry. These are decisions that have far-reaching effects on
those served by the ministry today and well into the future, including acquisitions, divestitures, partnerships, mergers
and capital allocations.
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A CHI Discernment Process workbook outlines the steps of the process and includes a resource directory to support
teams in their discernment process. The workbook enables participants to align their notes and resources with the
steps of the process, thereby increasing the ease of thoughtful reflection as they deliberate the decision. The process
details steps that, oftentimes, take place over time rather than any one moment. Perspectives emerge only as questions
are asked and decisions are made when participants are ready to commit to a course of action in the name of Catholic
Health Initiative’s mission and core values.

Kevin Lofton
President and CEO, Catholic Health Initiatives
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Catholic Health Partners
Cincinnati Ohio

System Scorecard and Executive Evaluation
Creating a System Scorecard to measure strategic progress, while simultaneously integrating this tool into the
Executive Evaluation Process, has been an important tool for advancing CHP’s culture and strategy. Over the past 13
years this Scorecard has focused our culture to emphasize quality and performance results. It has also created a healthy
balance between team work and individual performance while advancing the System’s Mission through prioritized
strategic objectives.
CHP has evolved a balanced evidence-driven scorecard benchmarked to top quartile results across a spectrum of
strategy-driven quality, human resources, and stewardship measures. The Scorecard is a by-product of the System’s
Strategic Plan and is used to evaluate the corporate office team and the regional teams in our System by their
respective Boards (Attachment A).
Ultimately, the Scorecard determines gain sharing awards for all of CHP’s 35,000 associates. The Scorecard consists
of four distinct parts and approximately 20 individual measures. Part 1 of the Scorecard focuses on outcome measures
for quality, human resources and stewardship. Part 2 of the Scorecard measures progress on system wide strategic
initiatives and is more process oriented (i.e. implementing a standard digitized health record throughout CHP). Part 3
of the Scorecard focuses on individual objectives related to the leader’s particular position. Finally, Part 4 is a threshold
or a screen that determines the eligibility for incentive compensation for the entire team. There are three thresholds
(community benefit, quality and financial) or screens that must be achieved before the incentive compensation is offered
to associates. The Part 1-3 results then determine the level of incentive compensation for the individual and the team.
Fundamentally, the Scorecard has driven our Board conversations – markedly moving those conversations from financial
issues to quality and talent management issues.
The Scorecard creates teamwork because the top 600 leaders in CHP have it incorporated into their individual
evaluations. The Scorecard creates focus because it forces management and the boards to identify, define and measure
the key strategic objectives for the year. The structure of the Scorecard allows results to be customized for regional team
performance and also consolidates results for the corporate office leaders. Part II of the Scorecard allows for promotion
of system-wide initiatives across all Regions and Part III of the Scorecard allows for a focus on individual performance
priorities.
The Scorecard as a whole creates concrete measures for living our Mission that are approved by our boards each year.
Since inception, the Scorecard has had almost 50% of the objectives devoted to quality. The attached Scorecard has 9
quality-focused objectives: preventable harm, inpatient mortality, readmission rate, LOS, inpatient experience, diabetes
measures in physician practices, CarePath implementation, CMS core measures and patient safety culture survey results
from AHRQ. This commitment to excellence and quality helps bring our values to life in our evaluations.
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At year end, the System’s Scorecard results are compared to both targets and top quartile national benchmarks.
Each Board member then assesses these results and individually scores each objective. These Board scores are then
used by the full Board to complete the Executive Evaluation Process.
The Scorecard is the core of our executive evaluation process and drives our culture and Mission by explicitly defining
and measuring our priorities. That process also incorporates a rigorous 360 assessment (colleagues and direct reports)
and behavioral assessment (CHP Board members and Regional Board members).
As part of the CHP executive compensation process, independent auditors perform a review of the CHP Incentive
Compensation Plan to validate the accuracy of data reported on the System Scorecard, as well as the reported system
thresholds. Additionally, an audit to validate the accuracy of CHP Board evaluation scores, as summarized for the
Compensation Committee review is provided. Attachment B is a diagram of the CHP Executive Performance
Evaluation Model.

Michael Connelly
President and CEO, Catholic Health Partners
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2011 Annual Plan
CHP System Scorecard
as of 1/20/2012
PART 1 OPERATIONAL
PERFORMANCE MEASURES
(KRA)

Preventable Harm
(Quality)

2010
(Latest
Available)

0.24%

2011
TARGET

BENCHMARK

0.19%

0.22%
Harm Measures, by
definition, are usually
preventable.
"Benchmark" is
Premier Top Quartile.
Benchmark includes
hospitals with
preventable harm
events

CURRENT

STATUS

COMMENT

Through December, there has been a 56% reduction in harm from our 2008 baseline and a 29% reduction
compared to last year in the five (5) harm measures used for the Part 1 objective. Current performance, at
0.17%, is exceeding the 2011 target of 0.19%. Year-to-date, 284 patients have experienced one or more of the
five harm events used in the Part 1 definition. During the year we report seven (7) stage 3 or 4 pressure ulcers,
down 74% from 2010. Falls and trauma, which had been a challenge in 2010, have declined 20% since last year.
Post-op deep vein thrombosis/pulmonary embolisms did not decrease in 2011, but are down 52% since 2008;
post-op sepsis is down 21% since 2010, and central venous catheter related bloodstream infections are down
42% since last year.

0.17%
(284 patients
harmed)

December YTD

Inpatient Mortality
(Quality)

0.49
(1.46% unadjusted)

0.55

0.55

Through December, the risk adjusted mortality observed to expected (O/E) ratio is better than target and has
performed better than top decile in 8 of the last 12 months. Unadjusted mortality rates finished the year at 1.47%.

0.54
(1.47% unadjusted)

December YTD
Raw rates increased; acute O/E ratio declined to 0.95. System OE ratio is better than expected (target </=.99).
Monthly rates demonstrate a decrease in variation. Decreased variation seems to indicate two things: (1) the
readmission population does appear to be “sicker” and (2) teams have had success in tackling low-lying
opportunities – stronger discharge planning for those readmitters who are less acutely ill, more reliable
assessment and discharge processes, more cross-continuum collaboration and alignment. All facilities have
detailed action plans. CHP home office staff is conducting readmission system tracers to provide additional
feedback and identify barriers. For 2012, the readmission metric will move from a raw rate to an OE ratio and
count readmitted patients only once, rather than serial readmissions to better matches CMS’ method.

2010 Jun - Nov
Baseline:
Readmission Rate
(Quality)

LOS (Quality)

Acute Care: 21.0%
Home Care
(Risk Adjusted):
24.4%

1.07

Acute Care: 20.7%
Home Care: 19.1%

Acute Care: 19.6%
Home Care: 15.0%

Acute Care: 21.7%
Home Care: 24.5%

Acute Care: Nov YTD Benchmark: Acute care based on CMS Hospital Compare top quartile for readmission to any US
Home Care: Dec hospital; Home care based on Strategic Health Partners database top quartile.
YTD

1.04

1.00

Through December, the geometric mean length of stay (GMLOS) O/E ratio has outperformed prior year, and is at
the 2011 target; the O/E ratio is 1.04 compared to prior year ratio of 1.07. YTD unadjusted LOS is 4.09 days
compared to prior year of 4.23 days. This equals an approximately 22,000 day reduction from prior year,
representing an $11M reduction at $500 per day.

1.04
December YTD

Inpatient Experience
(Quality)

26%

35%

46%
Top Quartile
(VBP Attainment
Rate)

Through December, the patient experience composite score is continuing to rebound following poor 1st quarter
performance; overall performance is 26%, slightly higher than in 2010 performance. Performance remains well
below our target of 35%. November performance was 35%. Monthly value based purchasing (VBP) points
have been at or above 30% of total points for 6 of the past 7 months.

26%

December YTD

Minority Retention Rate
(Human Potential)

86.5%

87.2%

88.2%

Minority Retention Rate declined 1.1% in 2011 while All Associate Rate declined 0.8%. However, Minority
Engagement (Gallup) reached parity with all associates, and both the absolute number and the percentage of
minority associates increased in 2011. The 2012 objective will focus on % diverse in SLT.

85.4%
2011

Associate Engagement
(Human Potential)

3.93

Primary Care Provider Recruitment
(Physician Engagement & Growth)

55
(Target: 37)

Net/Net Patient Revenue/Provider FTE
(Physician Engagement & Stewardship)

4.02

37

$324,073

$345,750

2.9%

3.1%
(Stretch)

4.00

N/A

N/A

2011

System improvement was broad-based, with six facilities achieving meaningful improvement (Mercy Tiffin, St.
Vincent, St. Rita's, St. Charles, St. Elizabeth and Community Mercy) and two experiencing a statistically
significant decline (St. Joseph and Marcum and Wallace). Minority engagement increased more than overall
engagement; and at 3.91 it is statistically at parity with overall engagement. Benchmark is Gallup
Organization Grand Mean for healthcare 50th percentile. Database contains 511 hospitals with 1.5 million
workers.

December YTD

Target is 90% of the 2011 plan for family practice, internal medicine, general pediatrics and their associated midlevel professionals. 2011 Target excludes MHP-NEPA and TN recruitment plans. Regional targets are set at 90%
of their plans on each region's respective Part 1. Recruitment is defined as "new to the community", not
employment.

3.97

45

$341,627
December YTD

Operating Margin (%)
(Stewardship)

2.7%

3.3%
December YTD

TARGET: set annually based on baseline measure, benchmarks, and current /prior performance with input from the appropriate EMT committees
(Quality, Mission, HR, etc.), RCEOs and LTM. Targets are set to insure steady progress towards achieving top quartile within a specified time frame
(or to maintain/improve performance at top quartile).
BENCHMARK: represents the "best practice" known for a specific metric. CHP uses as many top quartile national measures from external sources as
are available. Benchmark data in health care can vary widely by level of maturity.

Net/net patient revenue is based on all employed providers--physicians and mid-level providers. Year-end 2011
was 5.4% higher than 2010 baseline, but trailed 2011 Target by 1.2%. The largest cause for this variance was
due to the unmet employment goals of several high revenue producing specialist physicians. Target is based on
2011 OFP budgeted revenue.
3.1% is the operating margin adding back the contingency.
Benchmark and Target are consistent with the 5 Year Strategic Financial Plan, rather than the 2011 OFP
(the "budget").
Superior - Current performance is > 5% better than benchmark (external only)
Excellent - Current performance is at Benchmark or Target
Progress - Current performance is better than prior year but not at Target
Poor - Current performance is < Prior Year

Attachment A
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2011 Annual Plan
CHP System Scorecard
as of 1/20/2012
PART 2: STRATEGIC OBJECTIVES

TARGET

~ All employed PCPs report the
Identify and track quality indicators for owned
Diabetes 5 (D5)
physician practices.
~ Create infrastructure for
(Quality & Physician Engagement--Grossbart;
collecting and reporting
Copeland)
readmissions

CURRENT

Completed

Status

Comment
~All employed PCPs report the Diabetes 5 (D5):
Physician level reports are now available on CHP’s
internal web site and have been shared with regional
physician leadership.
~D5 performance score: 19%
~Readmissions: Healthspan's Infomed data warehouse
has been redesigned to identify hospital readmission
rates by attributed PCP and available in Q4 2011.
Humana has provided hospital readmission rates by
attributed PCPs.
~CHP readmission rate for patients attributed to CHP
Physicians: 15%

Complete Year 2 milestones of CarePATH
strategy.
(Quality--Sykes)

~ Go-Live at HMHP (3), Jewish
and all identified owned physician
practices.
~ Expanded metric set

HMHP - August 21st
Toledo (Ambulatory) October 24th
CMHP - November 13th

The November 13th Springfield implementation was
successful and completes the scheduled installs for
2011. The Toledo ambulatory implementation on
October 24th completed the ambulatory
implementations for 2011. We attested for meaningful
use and are receiving 26.1 M.

Address associate health claims and cost of
health care claims.
(Human Potential--Gage)

~ Standardize and improve CHP's
management of associate health
plans
~ Reduce rate of increase to
<10%

3.6% increase
(Nov. YTD 2011 vs. 2010)

3.6%, like last year's result (2.3%), sets CHP's
trend far below the U.S. average. CHP's
effective cost control is due in part to changes in
plan design, vendor management, and insourcing stop loss to the CHP captive.

Strengthen infrastructure of employed
physician practices.
(Physician Engagement--Copeland; Gravell)

~In-source and standardize employed
physician business office (CBOs) by
12/31/11
~Conduct pilot in 10 CHP program
practices to continue transformation to
Patient Centered Medical Home.

~CBO/CPBC on target with
addition of Lima & Lorain in
Q3. Pre-Service Centers
(PSCs) established in all
regions.
~PCMH on target.

The Corporate Physician Business Center is
successfully expanding back-office support.
NO & SWO are targeted for consolidation into
the CPBC Q1 2012. PSC's in place and
expanding functionality. Transforming CHP
employed practices into NCQA recognized
PCMH's is advancing with each region
developing a specific 2012 rollout plan.

Advance the quality and efficiency of the
emergency services provided in each CHP
Emergency Department.
(Growth--Copeland; Grossbart)

Decrease by 5% median time for
emergency department arrival to
ED departure for admitted
patients among facilites above the
national median.

Selected Emergency
Departments have decreased
Median LOS from 320 to 303
minutes against a target of 303.

Among the 9 facilities identified with opportunity for
improvement, the overall admitted median LOS though
September has improved at 6 of 9 facilities and 3 of 9
have achieved target. Overall, median admitted LOS
for these nine facilities hospitals has declined from 320
minutes in 2010 to 303 minutes against a target fo 303.
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2011 Annual Plan
CHP System Scorecard
as of 1/20/2012
PART 3: CONNELLY

TARGET

CURRENT

Status

Comment

Complete

Sale of Northeast PA assets to Community Health System
complete effective May 1, 2011. Distribution of proceeds
complete to all parties. Sisters of Mercy, Mid-Atlantic
Community Foundation and Scranton Civic Foundation formed
and operational. Re-named Regional Hospital of Scranton,
Tyler Memorial Hospital and Nantikoke Hospital running under
ownership of CHS.

Complete

Sale of East Tennessee assets to Health Management
Associates complete effective October 1, 2011. Distribution
of proceeds complete to all parties. Remainder Mercy
Foundation, Trinity, and new diocesan foundation, St. Mary's
Legacy Foundation, formed and will be operational by January
2012. Former Mercy Health Partners and all affiliates now
running under Tennova banner for Health Management
Associates.

62%

AHRQ Patient Safety Culture Survey: The survey
results identify a small improvement in 2011, to 62%
from 61% in 2009 and 58% - 2007. OB, error reporting,
and select facilities showed significant improvement.

Foster development of ACOs with Medicare or ~ Complete CHP market
other payers in selected regions. (Copeland - assessments in each region
Growth)

All Region Market
Assessments completed

Market assessment in each region to assess our
readiness for payment reform, including
participating in the Medicare ACO progam and
other Payer's risk sharing agreements.

Strengthen CHP ability to invest in health care
Days Cash On Hand >170
redesign. (Gravell - Stewardship)

226

Target is a stretch goal above 2011 OFP budget
of 167 Days Cash on Hand.

Complete transaction for sale of assets in
MHP-NEPA region. (Starcher - Growth)

Transaction successfully
negotiated and closed.

Implement preferred strategic option for MHP- Transaction successfully
TN region. (Starcher - Growth)
negotiated and closed.

Increase perception of patient safety as
2011 target: 64%
measured by AHRQ Survey on Patient Safety
2009 Score: 61.1%
Culture. (Grossbart - Quality)
2007 Score: 58.3

Advance CHP's talent management strategy. Initiate formal Mission formation
(Gage - Human Potential)
program/process for leaders

December
YTD

Complete
New 2012 Part 2 will standardize
leadership and formation
program/process across CHP

Standard guiding principles developed and adopted.
New Leader Orientation re-designed, CHP Leadership
Video produced and introduced at LDI. New 2012 Part
2 will standardize adoption of these plus a day of
renewal for RN leaders (successfully piloted in 3Q
2011) and RISEN for front-line employees.
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2011 Annual Plan
Incentive Thresholds
as of 1/20/2012
Annual Incentive Metrics

Threshold

CURRENT

Affordability as measured by Net Income
margin % (excluding interest rate swap,
impairment and loss on advanced refunding
of debt)

2%

2.1%

Community Benefit

$294.3M

Status

Comment

Investment losses in 3rd and 4th quarters
affected metric.
December YTD

$345.7M
December YTD

Overall ACM Score

85.0%

94%

Data harvested through November 17, 2011.
October 2010 September 2011

Background and Definitions:

Incentive Compensation Thresholds are established as minimum affordability and performance levels for executives to be eligible for incentive compensation each year. At the
December 2010 Compensation and Evaluation Committee meeting the Committee will review and recommend 2011 incentive metrics to the CHP Board of Trustees for final approval.
Management will be recommending the following metrics:
Net Income Margin % - Excess revenue before discontinued operations divided by total net operating revenue + total non-operating revenue (excluding interest rate swap,
impairment and loss on advanced refunding of debt). Proposed Threshold is 2% Net Income.
Community Benefit - Expenses identified as benefits to the underserved and/or community at large. Proposed Threshold is 90% of budgeted community benefit.
Overall ACM Score - Overall ACM score measures total percentage of patients who received all appropriate care for heart attack, heart failure, pneumonia, or surgical care.
Threshold is 90% of the top quartile benchmark for the overall appropriate care measure. Proposed threshold is 83.8%.
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Eligibility for Incentive Compensation has 3 Thresholds:
90% Budgeted Community benefit
2% Net Income
90% Quality Score

Incentive Compensation Stretch Objectives:
The actual level of compensation is based on CHP System Scorecard performance and limited to
board approved ranges. At least 75% of Part 1, 2, and 3 objectives on CHP System Scorecard must
be achieved to be considered for targeted incentive compensation

Factors Used to Adjust Base Compensation
 Current position in the pay range
 Years of experience at current level and tenure with CHP
 Leadership (leading system initiatives or representing the system on national/regional level)
 360 Review by colleagues
Attachment B
24
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4/12/2012

CHRISTUS Health
CHRISTUS
Health
Irving,
Texas
Irving, Texas

Generative
Governance
Generative Governance

As CHRISTUS Health neared its tenth anniversary, having been formed by the joining of two 140‐year‐old
As CHRISTUS Health neared its tenth anniversary, having been formed by the joining of two 140-year-old Catholic
Catholic health systems, its governance process and structure were common: an engaged group of
health systems, its governance process and structure were common: an engaged group of health care professionals
health care professionals and women and men religious focused on their fiduciary and mission‐oriented
and women and men religious focused on their fiduciary and mission-oriented duties of guidance and oversight.
duties of guidance and oversight. Indeed, this had served the system well after the merger by creating a
Indeed, this had served the system well after the merger by creating a focus on developing culture, creating new
focus on developing culture, creating new processes and a greater focus on operations to ensure a
processes and a greater focus on operations to ensure a return to stability and strength.
return to stability and strength.

As the
system’s
second
decade
dawned,
the governing
boardboard
beganbegan
to increase
its focus
governance
itself — its
As the
system’s
second
decade
dawned,
the governing
to increase
itson
focus
on governance
makeup,
ultimate
purpose
— withpurpose
the intent
create
board
engagement
beyond the oversight
itself role,
‐‐‐ itsand
makeup,
role,
and ultimate
‐‐‐ to
with
the even
intentgreater
to create
even
greater board
of operations
and
monitoring
of
finances
so
critical
in
the
early
years
and
challenge
members
to
shift
to other
engagement beyond the oversight of operations and monitoring of finances so critical in the
early
years
approaches.
and challenge members to shift to other approaches.
Guided
by the
work
of Chait,
Ryan
andand
Taylor
in in
Governance
as Leadership:
Reframing
the Work
of Nonprofit
Boards,
Guided
by the
work
of Chait,
Ryan
Taylor
Governance
as Leadership:
Reframing
the Work
of
the CHRISTUS
board
chair
embarked
upon
a
process
that
would
embrace
the
authors’
three
levels
of
governance:
Nonprofit Boards, the CHRISTUS board chair embarked upon a process that would embrace the authors’
fiduciary,
generative.
three strategic
levels of and
governance:
fiduciary, strategic and generative.

Fiduciary

Governance
Leadership

Strategic

Generative
The CHRISTUS board, like most, typically worked within a preferred position on the triangle. Their work
shortly after the merger tended toward fiduciary ‐‐‐ embracing the “familiar” board work of financial
Theoversight;
CHRISTUS
like most,oftypically
workedtowithin
a preferred
positionand
on other
the triangle.
Their work shortly
legalboard,
responsibility
accountability
the sponsors,
members
key stakeholders;
afterand
theproviding
merger tended
fiduciary
embracing the
“familiar”
of financial as
oversight;
legal
policytoward
guidance
to the —
newly‐formed
system.
This board
focus work
was appropriate
CHRISTUS
responsibility
of
accountability
to
the
sponsors,
members
and
other
key
stakeholders;
and
providing
policy
worked to bring two health systems of over 20 hospitals in 11 markets into one system. During this guidance
to the
newly-formed
This
focus wasand
appropriate
as CHRISTUS
worked facility
to bringdivestments,
two health systems of over
phase,
the systemsystem.
stabilized
operations
finance with
the board through
20 hospitals
in
11
markets
into
one
system.
During
this
phase,
the
system
stabilized
operations
and finance with
consolidation of markets and ending relationships with some physicians and insurance companies.
the board through facility divestments, consolidation of markets and ending relationships with some physicians and
insurance
companies.
After the
first formative years, however, the board more clearly shifted its focus to a greater emphasis
on strategic thinking and decision making. This focus involved more problem solving, an immersion in
strategic planning, and critical strategic decision‐making by board members. For CHRISTUS, this resulted
in some significant, longer‐range visioning and planning, and let to its first “Futures Task Force, ” an 18‐
86 month process of research, learning, visioning and strategic discussion that set a course for its next 10
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After the first formative years, however, the board more clearly shifted its focus to a greater emphasis on strategic
thinking and decision making. This focus involved more problem solving, an immersion in strategic planning, and
critical strategic decision-making by board members. For CHRISTUS, this resulted in some significant, longerrange visioning and planning, and let to its first “Futures Task Force, ” an 18-month process of research, learning,
visioning and strategic discussion that set a course for its next 10 years. The board engaged with management in
developing specific scenarios of future states of health care, from those gleaning the directions that would form the
base for the annual strategic planning process.
The results of the strategic thinking at the board level resulted in
CHRISTUS entering the international health care arena by forming
a partnership to create the CHRISTUS Muguerza Health System in
Mexico, originally a two-hospital system which has since grown to seven
hospitals and a network of clinics and ancillary services.
The true governance “breakthrough” occurred in recent years as the
CHRISTUS board added the third mode of governance – the generative
mode – to its work, purposefully examining opportunities and challenges
from a broader perspective. Using the knowledge and data gleaned
from the fiduciary and strategic modes, the board uses its insight to
create fresh understanding of complex and ambiguous situations. At
CHRISTUS, this is done by asking generative questions to flesh out
different perspectives and viewpoints; by noticing clues, trends and
patterns; and by seeking different frames of reference. It is evidenced
when board members ask the questions, “What is this telling us about
or organizational story or direction,” “How does this underscore our
visioning and take us to the future,” or simply, “What is the underlying
question we are really discussing?”

CHRISTUS Governance Principles
The CHRISTUS Health Principles of
Governance, adopted in 2010, provide a
frame for the health system’s board to
guide its pursuit of governance excellence
and innovation:
• Commitment to integrity in Mission,
Vision, Core Values and Catholic identity
which reflects incarnational spirituality in
governance policies and procedures.
• Commitment to simplicity in governance
structures and practices.
• Commitment to communication among
sponsors, governance to governance
and governance to management.
• Commitment to systemness in
governance.
• Commitment to continued Catholic and
faith-based formation and development
for governance leaders.

This mode of thinking allows a board to make sense of the facts and bring a different value than just reacting to them.
It creates discussion and ideas that then can be translated into specific strategies, policies, plans and tactics.
At CHRISTUS, this drew the board to consider and ponder the underlying focus of “incarnational spirituality” for
the system. CHRISTUS’ mission — to extend the healing ministry of Jesus Christ — undergirds its vision’s ultimate
purpose of providing services so that all “might experience God’s healing love.” As the basic charism of the founding
congregations, the Sisters of Charity of the Incarnate Word of Houston and San Antonio, this incarnational
spirituality, then, calls the board to ponder how every decision represents God among us.
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In practice, the CHRISTUS board embraced the generative mode to ask those compelling questions, but also to
develop a better governance process and structure. The governance committee took on a new role and led the board
to develop specific principles (see sidebar) and generated the second Futures Task Force for the system. In this task
force, board members embarked upon a more experiential learning, immersing themselves in environments such as
high-tech health care companies in Silicon Valley, New Orleans shortly after hurricane Katrina, and even touring the
poorest of the poor areas in need of reliable health care — all to inform those underlying questions that would provide
direction for the future. The result was solid strategic focus and parameters around which to lead the system to meet
the challenges and responsibilities of the future.
The new health care environment we live in calls us to develop new models of care and meet expanding needs in new
ways with fewer or different resources, and requires our boards to continue to challenge themselves to bring those
generative questions and ideas forward. It brings a deeper meaning to their board service, and provides invaluable
insight that we look to our boards to offer. Ultimately, it encourages the healthiest complimentary relationship with
management and fulfills the intended purpose of a board.

Ernie Sadau
President and CEO, CHRISTUS Health
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Kaiser Foundation Hospitals and Health Plan
Oakland, California

Board Committee for Community Benefit
The Kaiser Foundation Health Plan, Inc. and Kaiser Foundation Hospitals Boards of Directors exercise oversight
responsibility for the nation’s largest private, nonprofit health care system, commonly known as Kaiser Permanente.
That system consists of the 9 million-member Kaiser Foundation Health Plans, operating in eight regions covering
nine states and the District of Columbia, as well as Kaiser Foundation Hospitals, which owns hospitals or contracts
for hospital services in each of the program’s regions. The Kaiser Permanente Medical Care Program also includes
the eight regional Permanente Medical Groups, which are independent physician partnerships or professional
corporations with their own governance structure.
In 2001, the Board and the program’s outgoing CEO ordered an in-depth review of the program’s community
benefit activities. The internal study concluded that the community benefit work, then managed by a small staff
within the public affairs department, should be strengthened to enhance its internal and external visibility as well as
its strategic focus and leadership. When a new CEO, George Halvorson, arrived in 2002, one of his first actions was
to endorse the hiring of a senior executive-level leader for a separate community benefit program, Raymond J. Baxter,
PhD, and to create a standing Board committee solely responsible for community benefit. The new committee, which
was (and remains) a rarity among boards of health care organizations, was deemed one of the Board’s two “heart”
committees, along with the Quality and Health Improvement Committee, in contrast to the two “head” committees,
Finance and Audit and Compliance. Each Board member was expected to sit on one “head” committee and one
“heart” committee.
In 2003, Cynthia Telles, PhD, of the UCLA School of Medicine, became chair of the Board’s Community Benefit
Committee. Under her leadership, a committee charter was drafted and approved setting out the committee’s
responsibilities. These included strengthening the community benefit program and activities; regularly reviewing
its strategies, policies and performance; monitoring related internal control systems and risk assessment and
management; reviewing the design and management of major initiatives; overseeing related legal and regulatory
compliance; and increasing public recognition of community benefit activities.
The new committee soon approved a new funding policy setting a minimum threshold on annual community benefit
contributions by each region, resulting in greater program predictability and the sustainability of multiyear initiatives.
It also approved a strategic approach to community benefit funding that targeted four specific areas of activity:
charitable care and coverage, support of the health care safety net; community health initiatives (primarily focused on
healthy eating and active living); and development and dissemination of new health knowledge, focused on Kaiser
Permanente’s large health care research and health professions education program.
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From the beginning, committee members have been actively and deeply involved in oversight of the community
benefit department’s work. At each quarterly Board meeting, the committee receives an in-depth organizationwide review of one of the strategic focus areas, and once or twice a year it visits a specific region to review its entire
portfolio of activity. In addition, it receives detailed quarterly reports, for its approval, on each of hundreds of
grants exceeding $100,000 dollars a year, as well as regular reports on internal and external audits and federal and
state compliance issues, plus the annual Form 990 IRS reports relating to community benefit. A comprehensive
annual report, originally prepared only for the Board, is now also distributed to external stakeholders in print and in
electronic format on the department’s content-rich website.
Over the past decade, the committee has proved to have a powerful and direct impact on the scope, effectiveness, and
visibility of Kaiser Permanente’s community benefit work, which has grown to $1.8 billion in total investment as of
2010. For example, beginning with the onset of the recession, the committee was directly responsible for driving a
significant shift in community benefit programming that focuses resources on helping people who have lost their jobs
and health care coverage to obtain healthy foods and to qualify for public health care coverage programs. It has also
served as a powerful advocate for program performance measurement and evaluation.
Today, the department and its community initiatives and partnerships are widely understood and strongly supported
among Kaiser Permanente’s 170,000 employees and 15,000 physicians, and they are featured in extensive media
coverage in support of the program’s reputation and brand. At the leadership level of the organization, the existence
and work of the Board committee has underscored the message that the community benefit work is no less central
to Kaiser Permanente’s governance and mission than that of other standing committees, including Governance,
Accountability and Nominating, Audit and Compliance, and Finance.
In 2009, just seven years after it was created, the committee participated in another Kaiser Permanente governance
innovation that was as unusual in corporate boardrooms as the committee itself. It underwent a comprehensive audit
of its performance against its charter-defined authorities and duties, performed not by outside consultants but by
Kaiser Permanente’s own Internal Audit Services. The exercise was part of a unique ongoing series of internal audits
of board committees that began in 2008 with an audit of the board’s Governance, Accountability and Nominating
Committee.
The auditors interviewed the committee chair, the Board chair, the Governance committee chair, and community
benefit program management. They reviewed over a year of committee materials, and they observed three committee
meetings. The only hitch in the audit process came when auditors attempted to compare the committee’s activities to
best practices among the community benefit committees of other health care organizations. As the final audit report
noted, the only source identified for best practices for Board community benefit committees was the 2009 initial
report on Governance in Nonprofit Community Health Systems, by Prof. Lawrence Prybil and others.

90

Appendix B

“We heard from several sources outside Kaiser Permanente,” wrote the auditors, “that they looked to the Kaiser
Permanente community benefit program and the Community Benefit Committee for guidance on good governance
practices in nonprofit health systems….”
The audit concluded with a “Meets Expectations” opinion, the auditors’ highest possible rating, and a
recommendation to update one section of the charter, which was quickly implemented.

George Halvorson
Chairman and CEO, Kaiser Foundation Hospitals and Health Plan
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Mayo Clinic
Rochester, Minnesota

Mayo Clinic’s Vision for 2020

In November of 2007, the Mayo Clinic Board of Trustees
asked “Does Mayo Clinic have a plan for 2020?”
Mayo Clinic
Rochester,
Minnesota
The resulting initiative undertaken by the Board
of Governors
was a study dubbed the 2020 Initiative.
The purpose of the initiative: “To develop a tangible construct to describe what Mayo Clinic
should/must/will look like in 2020.”

Mayo Clinic’s Vision for 2020
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The 2020 Initiative was used as an anchor of vetted ideas that described Mayo Clinic as more than a place, more
than a research center, and more than an educational institution. The 2020 goals were bigger than ever before, and
the reach to patients and people needed to be greater as well. A construct that guided the concepts of our thinking
thinkinghere
was(within
patients
here
(withinpatients
our facilities),
patients
there
(with other
providers
at home),
and
was patients
our
facilities),
there (with
other
providers
or at home),
andorpeople
everywhere
people
everywhere
(recognizing
our
commitment
to
those
who
are
not
currently
patients).
This
(recognizing our commitment to those who are not currently patients). This construct has since been modified to
construct
has
since
to highlight
that
canthe
run,spectrum
grow, orof
transform
what
do across
highlight
that we
can
run,been
grow,modified
or transform
what we
do we
across
here, there
andwe
everywhere.
the spectrum of here, there and everywhere.
The new vision, “Mayo Clinic will provide an unparalleled experience as the most trusted partner for health care,”
vision,
“Mayo
Clinic
will of
provide
an has
unparalleled
as the
most trusted
partner
for has been
guidesThe
thenew
course
to 2020.
The
Board
Trustees
embracedexperience
the vision and
strategic
plan. This
support
health care,” guides the course to 2020. The Board of Trustees has embraced the vision and strategic
demonstrated through dialogue, discussion, approval of resource allocations and through interaction in many spheres
plan. This support has been demonstrated through dialogue, discussion, approval of resource
of influence.
allocations, and through interaction in many spheres of influence.
The new strategic plan has empowered the organization to think more broadly than Mayo Clinic’s walls. A new
The new strategic plan has empowered the organization to think more broadly than Mayo Clinic’s walls.
affiliation strategy was announced and provider groups around the nation are joining forces. Mayo has expanded
A new affiliation strategy was announced and provider groups around the nation are joining forces.
beyond
health
to transform
thehealth
healthcare
caretoand
information
delivery
process.
Engagement
in health
and wellness
Mayo
hascare
expanded
beyond
transform
the health
care
and information
delivery
process.
services
has
been
encouraged
through
a
location
at
the
Mall
of
America,
and
staff
are
developing
and
implementing
Engagement in health and wellness services has been encouraged through a location at the Mall of
new ways
to improve
theare
health
of people.
America,
and staff
developing
and implementing new ways to improve the health of people.
The refreshed
plan highlights
bringing
solutions
and hope
to patients.
Innovative
practice
techniques,
new discoveries
The refreshed
plan highlights
bringing
solutions
and hope
to patients.
Innovative
practice
techniques,
and ongoing
research
in
regenerative
medicine,
individualized
medicine
and
the
dissemination
of
the
learnings
from
new discoveries, and ongoing research in regenerative medicine, individualized medicine, and the
these dissemination
initiatives are essential.
This spreading
of best
practices
best knowledge
allowsof
Mayo
to continue
of the learnings
from these
initiatives
areand
essential.
This spreading
best Clinic
practices
and
offering
theknowledge
best outcomes,
service
possible offering
while being
affordable.
best
allowssafety
Mayoand
Clinic
to continue
the best
outcomes, safety and service possible
while being affordable.
Mayo Clinic sees great challenges ahead, yet the board, the physicians, scientists and allied health staff are guided
sees
great challenges
ahead,
yet the Board, the physicians, scientists, and allied health staff
by theMayo
wordsClinic
of our
founders,
and our future
is clear.
are guided by the words of our founders, and our future is clear.

“I look through a half‐opened door into the future, full of interest, intriguing beyond my
power to describe, but with a full understanding that it is for each generation to solve its own
problems and that no man has the wisdom to guide or control the next generation.”
Dr. William J. Mayo on his 70th birthday

John H. Noseworthy, M.D.
President and CEO, Mayo Clinic

John H. Noseworthy, M.D.
President and CEO, Mayo Clinic
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In June, 2009, the Board of Directors made the decision to charter a Board Committee on Physician Engagement
(see Attachment A). The committee’s basic role is to assess and monitor progress of the strategy for integration as
set by the Board, and to recommend appropriate Board action concerning the development of integration in each of
their regional markets. The Board Committee undertook the responsibility of reviewing the integration arrangements
that were being proposed in the markets in order to make appropriate recommendations to the Board. They also are
reviewing the work that is being done to develop leaders – both physician leaders and lay leaders working together to
further the strategic aspects of the organization.
Today, the Board Committee on Physician Engagement meets prior to each Board of Directors meeting. It
consists of 6 individuals, including: the Board Chair; the President/CEO; a Sister of Mercy; a physician leader
who is President/CEO of a regional health system; the President/CEO of a northeastern health care system; and
a business leader in one of our Arkansas communities who had previously chaired a regional health system in that
area. The Committee reviews quarterly reports on the status of integration in Mercy’s markets, reports on leadership
development, and other key issues brought to their attention. They recommend action when necessary to the Board
of Directors, and report on the status of integration across Mercy.
As integration has developed in each of the regional markets, regional compensation systems have been designed
based upon the input of physicians and lay leaders in each of those markets. Today, several compensation systems
exist. All have similarities but also differences. Consideration is now being given to developing a system-wide
physician compensation design, with significant input from physician leadership throughout all the clinics. The Board
Committee on Physician Engagement is assuming the responsibility for overseeing this process.
The Committee’s activities are an important part of the Board’s function, given the importance of the integration
strategy throughout Mercy Health.
Today, integration is rapidly taking place throughout Mercy. At this date there are approximately 1550 physicians
who have entered into an integration arrangement or 33% of the active medical staff members throughout the system.
Mercy expects this number to continue to grow.

Lynn Britton
President and CEO, Mercy Health
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Charter
Board Committee on Physician Engagement
Adopted by the Board of Directors, Mercy Health System June 3, 2009
Purpose
The Committee on Physician Engagement will advise the Mercy Board of Directors on matters
related to Mercy’s integrated groups and strategy to pursue and cultivate integration in all of
our markets. Generally, its focus will include:


Integration
o Scope related to the total activity in the Region
o Review of arrangements involving the growth of the multi-specialty group
o Culture and its development



Leadership development



Compensation system

Ancillary to providing advice and input to the Mercy Board of Directors related to matters of
integration, the Committee will provide an environment for Mercy physician leaders to interact
with Mercy’s leaders and gain insight as to their approach to our challenges and opportunities.
Membership
Chair
Members:

Staff:

Ron Ashworth, Chairman Board of Directors
Lynn Britton, President and CEO SMHS
Sister Padraic Hallaron, RSM
Eric Jackson, General Manager, Oaklawn Jockey Club, Hot
Springs, AR
Ron Paulus, M.D., President/CEO, Mission Health System,
Ashville, NC
Ellen Zane, President and CEO Tufts-New England Medical
Center
Fred Ford, Senior Vice President Ambulatory Care
Shannon Sock, Senior Vice President Business Development
Donn Sorensen, Vice President Ambulatory Operations

Frequency
Committee will meet prior to each quarterly meeting of the Board. The Chairman may call ad
hoc meetings as necessary provided a minimum of four members are available.
Form of Meeting
Meetings will be held in person as schedules allow. If necessary, meetings can occur via video
conference, telephonic or other electronic formats.

Attachment A
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Providence Health & Services
Renton, Washington

Board “Checking In and
Checking Out” Practice
The simple yet profound statement “Know me, care for me, ease my way”™ has been adopted by Providence Health &
Services to describe the experience we seek to provide for each patient we serve. It is likewise an underlying belief that all
Providence people should recognize and model this behavior in their relationships within the system. An example of its
presence beyond direct patient care can be found in the manner in which the members of the System Board of Directors
enter into and close their quarterly meetings. The use of this tool for more than five years has served us well and we would
suggest it as an “exceptional best practice” because of the way in which it has contributed to strengthening relationships
and teambuilding among our system board members.
Arriving at the meetings from several regions of the nation, having left busy schedules and demanding positions in order
to give their time, experience, and talent in the governance of the system, the members need a way to “reconnect”. The
first item of business on the agenda of day one is relatively brief, but much valued. It is our “Checking In” session where
each member brings the group up to date on what is going on in her/his life at present. Directors share a variety of events
and activities which may be uplifting or sobering. Examples include recent vacation highlights, personal honors, the
birth of grandchildren and the illness or death of loved ones. Each person concludes the update with the phrase “and I’m
checking in” to signify that they are now fully engaged in the board meeting. This has become a way for us to stay current
with and supportive of each other and to build long-lasting bonds. It also has proven to be the vehicle that allows us to
focus as a team on the work ahead. Having shared with persons whom we value and respect what is uppermost in our
minds when we arrive, we are then ready to let go and enter into the business before us. Moreover, the thoughts that are
shared tend to ground us in what is really important in our lives and help us to focus together on our responsibilities as
trustees of Providence Health & Services.
Equally important in this process is the ending session of the meetings. Having concluded the work of the days of the
meetings and before departing from the board room, each member summarizes her/his experience of the meeting, its
accomplishments and also makes suggestions for improvements or additions for future meetings. Each then concludes and
signals a readiness to leave by merely saying to all “and I’m checking out”.
Easy to accomplish and really relatively inconsequential as to time used, this practice has proven to be valued and effective
in the development of the culture of our Board. It has also enabled members of the board to develop deeper and more
personalized relationships and to enhance their overall effectiveness as a team.

97

Appendix B

In reflecting on the use of this practice, the Chair of the Board, Sister Lucille Dean, remarked “So appreciated is this short
but personal manner of launching and concluding our meetings that when there has been an occasion to omit it, we can
count on the fact that at least one member of the board will point out the omission and request that we be more diligent
in following the practice. Our ability to work well together has been enhanced by the fact that we have come to know
more about each other as persons in a very meaningful way.”

John Koster, M.D.
President and CEO, Providence Health & Services
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Sutter Health
Sacramento, California

Restructuring Governance to
Enable Strategic Alignment
Sutter Health’s history is one of change, evolution, and initiative. In 2007, a number of strategic imperatives
compelled us to be proactive in evolving once again.
First, we recognized that several environmental trends threatened Sutter’s current business model. As the population
ages, health care costs accelerate, and reimbursements diminish, we face the business imperative and responsibility to
consumers to be more affordable. Second, we were aware that the variation across our multiple affiliate organizations
would not be acceptable in a new era of quality and cost transparency. To transform our processes across the system
would require unprecedented integration, standardization, and new operating paradigms. Lastly, we realized that
historical boundaries and definitions of community have expanded in today’s health care environment. We need to
act in a deliberate, coordinated manner to care for our patients across expanded geographies.
Sutter’s future success depends upon our ability to coordinate closely among our affiliates and reform our cost
structure. However, the overriding concern was that our organizational complexity would hinder our ability to execute
our strategy.
Sutter evolved over several decades from mergers and acquisitions of 27 affiliate organizations, with governance
fragmented across 55 separate corporations. To consider a system-wide strategic decision, it required a minimum of
six to 12 months to move through 20 review steps and gain agreement. Consequently, 17% of Affiliate CEOs’ and
35% of System Executives’ time was spent on governance.
Acknowledging governance as a key enabler to strategic alignment, we decided to reassess our structures and
processes. A Governance Assessment Steering Committee, consisting of board members from affiliates and the
system, formed to oversee the assessment, evaluate options, and make recommendations. The year-long process
involved internal interviews, case studies, and forums to promote transparent, two-way communication. The
Committee evaluated approaches against the criteria of community benefit, financial sustainability, stakeholder
responsiveness, system performance, philanthropy and concluded:
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1) We need to act in a more unified manner. Consolidation of several functional areas and a regional approach to
service planning and delivery would facilitate higher quality, lower costs, and smoother intra-system coordination.
As stewards of community assets, the Sutter Board believed that not changing our governance would inhibit our
ability to innovate and lead in the transformation of health care delivery.
2) Merge affiliate organizations into five regions. This structure would enable the advantages of region-wide
planning but still keep strategy and communications close to local communities. However, philanthropy,
community benefit, and quality assurance should continue as local functions.
3) Regional board members should act as a single point of responsibility. To achieve integrated governance of
both our medical foundations and hospital corporations while maintaining two legally separate corporate entities
(a requirement in California), the two corporations would have “mirror boards” with concurrent meetings,
deliberations, and decision making (while subject to conflict of interest policies).
4) Additional supporting steps are needed to reinforce local/regional/system decision-making. Governance changes
alone would not assure future success, but rather facilitate and complement other necessary changes.

The Governance Committee evaluated and ruled out alternative approaches ranging from a single system board to
maintaining the status quo. The regional structure, on balance, was considered to be the best alternative to move
the organization forward. After initial findings were presented, 85% of affiliate CEOs polled were “very willing to
personally endorse these recommendations and be an advocate for regionalization.” With Board approval, regional
integration was executed over the next three years: five regional hospital and medical foundations merged with
appointed boards, key executives were named to fill new regional roles, and support functions were consolidated
regionally.
While Sutter Health acts as one entity in accessing capital and other select activities, the region is the core
accountable business unit to implement strategy, service planning, and physician planning. We believe our new
governance structure has enabled us to be more effective while maintaining sensitivity to our local communities.
The Sutter Health board and management continue to monitor and assess the effectiveness of the regional
governance model and believe that it has prepared us to be more efficient and flexible in the fulfillment of our
not-for-profit mission as we enter the era of health care reform.

Pat Fry
President and CEO, Sutter Health
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Sutter Health Governance in 2007:
 55+ Corporations (including subsidiaries and 20+ joint ventures
 40 Full Boards (26 Affiliate Boards, 1 Regional Board, 1 System Board, 12 Philanthropy Boards)
 750+ Board Members (Affiliate, System and Philanthropy/Foundation)investing 39,597 hours annually
 17,901 hours invested annually by management (estimated $4.1M in annual resource cost +
opportunity cost)
 20,782 hours invested annually by staff (estimated $1.9M in annual resource cost + opportunity cost)
 Affiliate CEOs spend ~325 hours annually or 17% of their time on governance
 System Executives spend ~683 hours annually or 35% of their time on governance

Sutter Health Governance in 2012:
 1 System Management Team
 1 System Board
 5 Regional Management Teams
 5 Regional Boards with local Committees
 Philanthropy Boards
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Trinity Health
Novi, Michigan

Founding Principles
At the time Trinity Health was founded on May 1, 2000, the new entity formed to sponsor Trinity Health, Catholic
Health Ministries, established guiding principles to direct the organization’s mission and development. These fifteen
principles are now referenced as the “Founding Principles” (Attachment A). These principles are based on Catholic
Social Teaching, most notably the moral imperatives to care for people who are poor and underserved, the sacredness
of human life, the common good of the communities we serve, stewardship of resources, and collaboration in decision
making – all of which guide our performance as a Catholic health system.
The intent of the Principles was to give Trinity Health the foundation on which to build a strong and unified health
system that drew strength from the legacies of its founding congregations. The founders understood that creating a
strong and unified system, would, in turn, help strengthen each of the local Ministry Organizations (hospitals) as they
strive to improve the delivery of health care in their local communities across the country.
The Founding Principles serve as a significant philosophical document outlining the expectations for the business
enterprise. These Principles guided development of the Board role and responsibilities document, which includes
the criteria and competencies for appointment to the Trinity Health Board of Directors. They also helped direct
efforts to purposefully shape the organization’s culture early in the formation of Trinity Health.
Twelve years after Trinity Health’s founding, the Principles continue to frame the responsibilities for governance
accountabilities, such as strategic planning engagement and a variety of stewardship responsibilities. The principles
also continue to serve as an accountability tool for both governance and management in assessing faithfulness to our
Mission and the congruence of the system’s priorities and strategic direction. For example, as Trinity Health takes
on new partners, the Principles serve as guideposts for integrating new organizations into the Trinity Health culture.
Additionally, when major business decisions are being made that have a significant impact on the organization, the
Principles are taken into account as part of the process used to determine the best course of action.
The members of Catholic Health Ministries, who also serve as the Trinity Health Board of Directors, have periodically
reviewed the Principles to assess the system’s faithfulness to them, and also their impact on Trinity Health and the
communities served. One of the amazing outcomes of the formal reviews of the Founding Principles is their enduring
quality. There has never been a single request or recommendation to delete or add to them. The Principles are
experienced as a living document that provides counsel, direction and affirmation to the Board and management
as they advance the ministry to carry out its Mission, Vision, and Values.

Joseph Swedish
President and CEO, Trinity Health
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Founding Principles of Catholic Health Ministries and Trinity Health
Catholic Health Ministries, the entity formed to sponsor Trinity Health, established several guiding principles to direct
the organization’s mission and development. These principles have been integrated with the principles articulated as
part of the system’s organizational design and are now referenced as the “Founding Principles.”
1.

Trinity Health will be characterized by a demonstrated commitment to persons who are poor and underserved,
with particular attention to the needs of women and children, working to assure access, recognition of health as
a basic social right, and effective advocacy.

2.

Trinity Health will be committed to the integration, assessment and development of mission in all of its activities,
decisions and strategies.

3.

In all of its actions and decisions, Trinity Health will recognize and respect the sacredness of all life, the dignity
of all persons, and the needs of the whole person - spirit, body and mind.

4.

Decision-making within Trinity Health will be characterized by the following attributes: social analysis and
mission discernment, reflecting a commitment to meeting the needs of the communities it serves, promoting
diversity, and locating decision-making at the most appropriate level.

5.

Trinity Health’s culture will be characterized by collegiality, interdependence and accountability, with respect for
the traditions of the founding organizations while creating its own mission and culture.

6.

Sponsorship in Trinity Health will be mediated through governance structures that enhance and promote a spirit
of a community of persons committed to the mission, full partnership of religious and laity in governance,
management and sponsorship, and continued reflection on the evolution of sponsorship.

7.

The members of Catholic Health Ministries, our sponsor, will possess the competencies so required, will be
committed to a personal and communal formation in sponsorship, and will be periodically assessed.

8.

Trinity Health will be committed to partnering with physicians to assure quality outcomes, cost-effective,
compassionate and accessible care.

9.

Trinity Health will be an active collaborator consolidating and rationalizing services in its markets and partnering
with Catholic and other health and social service organizations to improve the health and overall well-being of
those communities.

10. Trinity Health will strive to be the employer of choice, committed to the development of its human resources and
to creating workplaces that nurture the human spirit and respect diversity.
11. Trinity Health will leverage its strengths and geography in order to facilitate the sharing and adoption of best
practices and learnings across the System as well as to assure its financial stability.
12. Trinity Health through its corporate structure, services, and collective actions will add value, synergy and bring
economies to its members.
13. Trinity Health will act as a unified System, recognizing its interdependency in fulfillment of its mission and vision.
14. Trinity Health will develop and monitor standards for mission accountability, financial viability, patient and
employee satisfaction, quality enhancement and stewardship of its resources - human, financial, environmental.
15. Trinity Health will faithfully attend to the recruitment, development and retention of governance, management,
physician partners and staff.
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